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 ABSTRACT 
EFFECTS OF CARBOXYLATED NANODIAMONDS ON MACROPHAGES DURING 
AND AFTER DIFFERENTIATION 
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Old Dominion University, 2017 
Advisor: Dr. Christopher J. Osgood 
 
 
Nanodiamonds (ND) are a carbon-based nanomaterial that are increasingly being 
proposed for developing novel imaging techniques, as carriers of biomolecules and 
therapeutic drugs, as coatings for implants, and for other biomedical applications. The 
exceptional chemical, mechanical, and optical properties of ND make this material 
suitable in a wide range of fields. The application of ND in the biomedical field is attractive 
but requires more in-depth investigation into the safety of ND and its interactions with 
different cells and systems. The effects of ND on the immune system are not fully 
understood or investigated and there are several controverting reports regarding ND 
biocompatibility. Macrophages are found in almost all tissues of the body and are key 
players in the vertebrate immune system, maintaining homeostasis and initiating immune 
response to a wide range of pathogens and foreign or host mediators. I hypothesized that 
ND can affect macrophages and interfere with their functions, and aimed to study 
interactions of ND with these cells to better understand the potential impact of ND on the 
immune system. My studies included monitoring both cultured and bone-marrow-derived 
macrophages in vitro after different exposure conditions and assessment of their effects 
on cellular processes using molecular laboratory techniques. Results showed that these 
particles do not significantly increase cell death or changes in cell morphology. These 
 macrophages internalized ND via phagocytic and clathrin-dependent endocytosis in a 
time- and dose-dependent manner. The internalized ND localized to the cytoplasm 
without eliciting an inflammatory response in macrophages. Investigations on the 
macrophage functions showed that treatment of macrophages with ND did not affect their 
ability to respond to lipopolysaccharides. On the other hand, their endocytic activity was 
reduced significantly, irrespective of ND dose. Exposure of bone marrow cells to ND early 
during their differentiation did not affect their morphology or reduce the percent of cells 
expressing macrophage surface markers. Nonetheless, ND exposure reduced the 
number of surface markers expressed on each cell. My findings suggest that ND are not 
cytotoxic to macrophages at the tested concentrations, but they can interfere with 
macrophage functions and differentiation. Further studies are needed to explore the 
mechanisms by which ND suppress macrophages endocytic activity and expression of 
surface markers and the downstream impact of these suppressed immune functions. In 
addition, the effects of ND on other cells’ immune functions and expression of other 
immune mediators yet to be studied before concluding the immunotoxicity or compatibility 
of ND. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Nanomedicine  
The study and application of nanometer-sized materials in medicine opened the 
door for new diagnostic and therapeutic strategies. Nanomedicine has gained exponential 
interest with highly promising results in the last decade. Some of the advantages of using 
nanomaterials in medicine are early diagnosis of diseases at the molecular level, 
improved drug delivery and targeting, and the reduction of side effects from overdosing 
and nonspecific or off-target effects. Hundreds of nanoparticle-containing products such 
as food and food packaging products, health and fitness, cosmetics, clothing, home and 
automotive products, reached the market in consumer products and more than 50  
therapeutic drugs such as liposomal doxorubicin (cancer), pegylated interferons (hepatitis 
B and C), and carbohydrate-coated iron oxide (anemia of chronic kidney disease), have 
already entered clinical practice and many more are in the pre-clinical or clinical phases 
(Zhang et al. 2015; Min et al. 2015; Caster et al. 2017).  
Advancement in the nanotechnology field made it possible to manipulate 
nanoparticles to achieve or enhance any required properties. Nanoparticles-based 
therapeutics can overcome many complex problems with the old therapeutic 
interventions. These nanoparticles can be designed to stay in the body long enough to 
reach their target and avoid removal by immune system components. They can also be 
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designed to concentrate more drug molecules in each particle, accumulate and deliver 
the drug to the targeted tissue but not to other healthy tissues, and to overcome biological 
barriers (Rizzo et al. 2013; Arranja et al. 2017). 
Inorganic nanoparticles such as gold, silver, fluorescent quantum dots and iron 
oxides have been widely tested for diagnosis and imaging applications (Kolosnjaj-Tabi et 
al. 2017). Their unique physical and chemical properties such as inertness, stability, 
optical or magnetic properties made these materials suitable for these applications 
(Huang et al. 2011). With their higher sensitivity and specificity, inorganic nanoparticles 
may allow for diagnosis of early stage cancers and to better classify specific types of 
cancers (Huang et al. 2011; Kolosnjaj-Tabi et al. 2017).  
Nanotechnology enabled the combination of diagnosis, targeted therapy, and 
monitoring the efficacy of drugs using a single platform in so called theragnostic 
nanomedicine (Figure 1.1). These platforms offer less invasive imaging techniques or 
enhance the current techniques and at the same time, lower the opportunity to expose 
the patient to multiple potentially harmful drugs and imaging contrast agents (Kolosnjaj-
Tabi et al. 2017). In addition to their valuable roles as theragnostic nanoparticles, these 
platforms are highly useful for personalizing nanomedicine-based therapeutic 
interventions (Rizzo et al. 2013). 
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Figure 1.1: Nanoparticles-based theragnostic medicine. Nanoparticles can be designed 
to achieve diagnosis, targeted therapy, and monitoring the efficacy of drugs. The 
nanoparticle core can be conjugated with proteins or ligands to target specific tissue or 
cell type and with tracking agents for imaging and monitoring nanoparticles in vivo along 
with therapeutic drugs in the same platform.  
 
 
Nanoparticles have also been suggested as adjuvants or delivery vehicles for 
vaccines. Traditional vaccines contain attenuated or killed microbes or microbial 
components and these have been essential for control of many infectious diseases. 
However, some of these vaccines fail to offer protection or are not safe to use specifically 
in the growing population of immunocompromised people (Gregory et al. 2013). For 
example, two vaccine candidates for Staphylococcus aureus (S. aureus) infection have 
been evaluated previously but failed to demonstrate efficacy and no licensed vaccine is 
currently available against S. aureus infection (Giersing et al. 2016). A recent study on a 
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nanoparticle-based S. aureus vaccine reported high protective immunity against this 
infection (Wang et al. 2016). For many other infectious diseases such as HIV, malaria, 
dengue, and Chagas disease, no vaccine is available to provide good protection. 
Nanoparticles can serve as a delivery vehicle for vulnerable antigens such as microbe’s 
isolated proteins, polysaccharides, or naked DNA molecules protecting them from 
degradation and enhancing their presentation for immune cells.  
 
1.2 Carbon-based nanoparticles 
A wide variety of starting materials have been suggested for biomedical 
applications in addition to the many possible modifications to enhance their 
biocompatibility and efficiency. Carbon-based nanoparticles such as nanotubes, 
graphene, fullerenes, and nanodiamonds (ND), have been tested for different imaging 
and therapeutic modalities (Fisher et al. 2012; Khabashesku et al. 2005). All of these 
particles are pure carbon materials that differ in their molecular configuration (carbon 
allotropes) (Figure 1.2).  
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Figure 1.2: Carbon based nanomaterials. Graphene sheet is the parent for these carbon 
allotropes. Single-walled carbon nanotubes (SWNT) are cylindrical tubes, multi-walled 
carbon nanotubes (MWNT) are concentric cylinders, fullerenes are spherical, and 
nanodiamonds (ND) are rounded or faceted crystals.   
 
 
The six electrons of carbon atom are arranged as 1s2, 2s2, 2p2. One of the s 
orbital electrons can promote to the empty, higher energy p orbital due to the narrow 
energy gap between 2s and 2p electron shells, allowing carbon to hybridize into an sp, 
sp2, or sp3 configuration (Figure 1.3) (Mauter and Elimelech 2008). These different 
hybridization states affect the overall characteristics of the carbon compound. The 
trigonometric sp3 configuration dominate the carbon-carbon bond in ND while the planar 
sp2 state dominates in fullerene, nanotubes, and graphene (Ajayan 1999). By controlling 
variables including temperature and pressure during the synthesis of carbon particles, 
scientists are able to force the formation of these types of bonds producing the different 
carbon allotropes.  
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Figure 1.3: Carbon hybridization states.  
 
 
1.2.1 Graphene  
Graphene is the first known two-dimensional atomic crystal composed of a single 
layer of sp2-hybridized carbon atoms in a honeycomb lattice with exceptional structural, 
optical, mechanical, electrical, and thermal properties (Yin et al. 2015; Novoselov et al. 
2012). Geim and Novoselov won the Noble prize in physics in 2010 for their 
groundbreaking experiments using regular adhesive tape to isolate a single atom thick 
graphene from a piece of graphite. Different methods have been used for the mass 
production of graphene and its derivatives depending on the cost, quality and required 
properties of the product. The most common methods include chemical vapor deposition, 
mechanical, thermal, or liquid-phase exfoliation, and chemical, electrochemical, or 
thermal reduction of graphene oxide (Novoselov et al. 2012).  
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Since its first appearance in 2004, graphene evoked enormous interest to 
investigate its potential in several scientific applications (Geim and Novoselov 2007; Liu 
et al. 2013). This relatively new material found its path into a wide range of fields and 
showed promising results for its capabilities. In biomedicine, graphene and graphene 
oxide have been extensively studied for their use as sensors to detect biomolecules, drug 
and gene delivery vehicles, nanoprobes for bioimaging, phototherapy, and antimicrobial 
agents (Wang et al. 2011; Feng et al. 2013; Maleki Dizaj et al. 2015; Yang et al. 2013). 
More derivatives are being investigated particularly with the ease of functionalization of 
graphene and with the advancements in this rapidly growing area. 
 
1.2.2 Nanotubes 
Graphene is the building block of the carbon nanotubes where these tubes are 
formed from folding of the graphene sheets into the cylindrical structure. Single-wall 
carbon nanotubes (SWNT) and multi-wall carbon nanotubes (MWNT) have distinct 
features making them suitable for different applications. The inner diameter ranges from 
0.4 to 3 nm in the SWNT and from 0.4 up to few nanometers in the MWNT while the outer 
diameter of MWNT is 2-30 nm (Eatemadi et al. 2014). The length of the tube is relatively 
high compared to the diameter (typically in the micrometer range and up to several 
micrometers) which gives nanotubes the highest aspect ratio (length-to-diameter) 
compared to other nanomaterials (Akiladevi and Basak 2011; Kaushik and Majumder 
2015). Another interesting feature of carbon nanotubes is their high tensile strength 
(resistance to being pulled apart). The sp2 bonds between carbon atoms are stronger 
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than the sp3 bonds in diamonds and theoretically, these tubes may have tensile strength 
hundreds of times higher than that of steel (Eatemadi et al. 2014).  
Carbon nanotubes were first introduced by Somio Iijima in 1991 (Iijima 1991). Iijima 
used carbon arc discharge method to produce MWNT. This method applies a direct 
current between two graphite rods in a chamber filled with ambient gas to induce 
evaporation of the anode carbon which deposit on the top of the cathode producing 
MWNT (Ando and Zhao 2006; Eatemadi et al. 2014). Other commonly used methods to 
produce carbon nanotubes include laser ablation which uses a high-power laser to 
vaporize pure graphite, and chemical vapor deposition which involve chemical breakdown 
of hydrocarbons and deposition on a metal substrate (Cha et al. 2013; Kaushik and 
Majumder 2015; Eatemadi et al. 2014). Each of these methods has variations but in 
general, all of them produce similar yield rate and can produce both SWNT and MWNT 
(Eatemadi et al. 2014).  
In addition to their valuable capabilities for electronics, nanotechnology, 
manufacturing, and construction, carbon nanotubes were tested for many biomedical 
applications. Studies on interactions of bone cells (osteoblasts) and mesenchymal stem 
cells (MSC) with carbon nanotubes showed that these tubes positively affect bone 
formation by enhancing differentiation of MSC into osteogenic lineage, osteoblast 
proliferation, and expression of calcium and alkaline phosphatase (Elias et al. 2002; 
Khang et al. 2006; Stout and Webster 2012; Nayak et al. 2010). Other studies investigated 
the suitability of carbon nanotubes as in vivo biosensors such as tissue-implantable 
insulin sensor, and showed promising results for detection of biomolecules (Iverson et al. 
2013; Kruss et al. 2013; Bisker et al. 2015).  The ability to modify these nanotubes by 
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functionalization with biomolecules allowed the production of more effective materials 
enhancing biocompatibility and solubility in aqueous media (Eatemadi et al. 2014).   
 
1.2.3 Fullerenes 
Buckminsterfullerene, C60, is the smallest and the most abundant fullerene from 
the currently used preparations (Hirsch and Brettreich 2005). Fullerenes are composed 
of carbon hexagons, like graphene, but fused with pentagons to provide the curvature. 
Other larger fullerenes, in addition to the many manipulated derivatives, are also 
produced for specific applications. These spheres are less stable thermodynamically than 
graphite or diamonds and are less water-soluble. However, the solubility of fullerenes in 
organic solvents allowed the chemical modifications enhancing their solubility in aqueous 
media and stability (Schinazi et al. 1993; Yamago et al. 1995; Hirsch and Brettreich 2005).  
Production of fullerenes was first reported by Curl, Kroto, and Smalley in 1985 
which later led to a Noble prize in chemistry in 1996 (Noble prize.org 1996). They used 
the laser irradiation method to vaporize graphite producing clusters of 60 carbon atoms 
(C60) and 70 carbon atoms (C70) (Kroto et al. 1985). Since then, scientists have 
developed other methods to generate fullerenes and fullerenes derivatives. The first 
method to produce macroscopic quantities of fullerenes also included the vaporization of 
graphite but this method used resistive heating of graphite instead of laser irradiation 
(Kratschmer et al. 1990). Fullerenes were found in the sooting flames which led to new 
methods for synthesis of fullerenes based on combustion (Howard et al. 1991). Using 
different pressures, temperatures, and carbon to oxygen ratios, combustion of a premixed 
benzene, oxygen, and argon flames producing fullerenes in addition to other combustion 
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products (Hirsch and Brettereich 2005). Another method to produce fullerene is the 
pyrolysis of naphthalene in argon stream at 1000 °C which is based on the full 
dehydrogenation of naphthalene to produce C60 and C70 but in low yield (Taylor et al. 
1993). The yield and purity of fullerenes produced by the available current production 
methods vary and all require purifications after synthesis due to the use of metallic 
catalysts and by products of the production reaction.  
Due to the unique physical and chemical features of the fullerene family, and 
especially C60, these nanomaterials were tested in biological fields. Schinazi and co-
workers (1993) reported anti-HIV activity of a water-soluble fullerene C60 derivative in 
acutely and chronically HIV-infected cells (Schinazi et al. 1993). Two major targets were 
found for anti-HIV fullerenes derivatives; the anti-protease and anti-reverse transcriptase 
activities, which were enhanced by surface modifications of the fullerenes (Friedman et 
al. 1993; Friedman et al. 1998; Mashino et al. 2005). An interesting feature of fullerene 
C60 is its ability to quench various free radicals (Krusic et al. 1991). This feature is of 
special importance in biomedical field as it shows a higher efficiency than conventional 
antioxidants. In addition, fullerene can produce highly reactive singlet oxygens when 
exposed to light which can react with a wide range of biomolecules such as DNA 
(Arbogast et al. 1991; Markovic and Trajkovic 2008; Bosi et al. 2003). 
 
1.2.4 Nanodiamonds  
The nanometer-sized diamond particles are a new addition to the carbon-based 
nanomaterials and are currently available in different sizes (up to hundreds of 
nanometers) and surface chemistries (Figure 1.4). Synthesis of nanodiamonds requires 
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termination with functional groups or reconstruction into an sp2 carbon (Mochalin et al. 
2011). These functional groups can be oxygen- or nitrogen-containing groups which can 
be easily conjugated with other desired molecules. The rigid diamond structure is formed 
by the sp3 hybridization of carbon atoms with tetrahedral symmetry (Kaur and Badea 
2013). This hybridization state means that the four valence electrons of the carbon atom 
are engaged in a σ bond with the neighboring atoms resulting in a lack of free electrons 
and hence, producing a chemically inert core structure. This structure gives ND their 
outstanding properties such as chemical stability and extremely high hardness and 
strength. However, the chemical stability of the core does not hinder the ability of ND 
surface from engaging in interactions and modifications with chemicals and biomolecules. 
ND are chemically inert but can be easily conjugated with drugs or biomolecules which is 
essential for targeted therapy and diagnostic applications (Vaijayanthimala et al. 2015; 
Kong, Huang, Hsu et al. 2005; Kong, Huang, Liau et al. 2005). 
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Figure 1.4: Transmission electron micrograph of a single ND particle. The ND core is 
highly ordered sp3 carbons and the surface can be sp2 or functionalized with other 
groups. ND surface can be rounded or have facets like the one shown here. Reprinted 
with permission from (Shenderova et al. 2011. Surface chemistry and properties of ozone-
purified detonation nanodiamonds. The Journal of Physical Chemistry C. 115(20):9827-
9837). © (2011) American Chemical Society.  
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In addition to their unique optical capabilities, ND are now being produced with 
enhanced intrinsic fluorescence. Their fluorescence originates from crystal defects that 
form in their lattice during production. High energy irradiation of ND knocks carbon atoms 
out of the diamond structure creating vacancies which move closer to the nitrogen centers 
to produce the nitrogen-vacancy (NV) centers (Davies et al. 1992). Two types of NV 
centers are produced by this method; the neutral and the negatively charged centers 
which differ in their emission spectra (Mochalin et al. 2011). The neutral NV centers emit 
at 575 nm, weaker than the emission of the negatively-charged NV which peaks above 
700 nm with no signs of photobleaching or photoblinking (Davies and Hamer 1976; 
Gruber et al. 1997; Yu et al. 2005). Yet another type of fluorescence-producing center is 
the silicon vacancy (SiV) which were shown to be stable in as small as 1.6 nm ND (Vlasov 
et al. 2014). 
Production of ND is commercially achieved by three main approaches; detonation, 
high pressure-high temperature (HPHT), and chemical vapor deposition methods. 
Detonation of carbon explosives produces around 4-5 nm ND and is a relatively low-cost 
production method (Shenderova et al. 2002). These small ND are well suited for 
biomedical applications but they require extensive purification due to the impurities in and 
on their crystals (Kaur and Badea 2013; Shenderova et al. 2011). The chemical vapor 
deposition method is of major interest to produce ND films suitable for implant coatings 
due to their outstanding mechanical and wear-resistant properties (Gracio et al. 2010; 
Kaur and Badea 2013). The HPHT-ND are produced in large scale with a primary particle 
size >20 nm and are preferred for imaging and tracking applications due to their intrinsic 
fluorescence (Shenderova and McGuire 2015).  
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1.3 Biomedical applications of Nanodiamonds 
Among all carbon-based nanomaterial, ND stand out as the most biocompatible 
material and are increasingly being proposed as diagnostic, imaging, and therapeutic 
agents in biomedicine (Schrand, Huang et al. 2007; Kaur and Badea 2013; 
Perevedentseva, Lin et al. 2013; Lim et al. 2016; Vaijayanthimala et al. 2015). Their stable 
fluorescence makes it possible to track ND both in vitro and in vivo (Fang et al. 2011; Yu 
et al. 2005; Fu et al. 2007; Schirhagl et al. 2014; Hemelaar et al. 2017). In addition to their 
fluorescence potential, ND can easily be conjugated with fluorophores to enhance their 
fluorescence. ND can also be conjugated with biomolecules to serve as a nano-carrier of 
drugs and biomolecules. However, unlike the other carbon-based nanomaterials, 
susceptibility of ND to biodegradation is still unknown (Bhattacharya et al. 2016).   
 
1.3.1 Imaging and tracking applications 
The HPHT-ND are preferred for imaging applications due to the ability to 
incorporate hundreds of parts per million of NV centers producing high fluorescence 
(Mochalin et al. 2011). Fu et el. (2007) studied the fluorescence of 100 nm ND and found 
that they can function as a tracking agent for biomolecules and intracellular interactions 
(Fu et al. 2007). Carboxylated ND were used for tracking cell division and differentiation 
and were found to be equally divided between the two daughter cells without affecting 
gene or protein expression (Liu et al. 2009). In another study, ND were used to image 
interactions of transferrin with its receptor on HeLa cells (Weng et al. 2009). This study 
also showed that conjugation of ND with transferrin did not affect the fluorescence of ND 
or the binding of transferrin to its receptor (Weng et al. 2009). 
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Several in vivo studies also investigated the usefulness of ND as imaging or 
tracking agents. Haziza and co-workers (2017) used fluorescent ND to measure changes 
in intraneuronal transport induced in the brain of two transgenic mouse models that mimic 
the slight changes in protein concentrations found in the brain of brain-disease patients 
such as autism and Alzheimer’s disease (Haziza et al. 2017). Another group tracked the 
intradermally, intraperitoneally, and subcutaneously administered fluorescent ND in mice 
and rats and reported that these particles are non-toxic and suitable for long term in vivo 
imaging (Vaijayanthimala et al. 2012). Studies of the use of fluorescent ND for imaging 
were also tested by other groups in cultured cells, Caenorhabditis elegans (C. elegans), 
and mice and reported good imaging contrast even in the presence of background 
fluorescence (Mohan et al. 2010; Igarashi et al. 2012).   
 
1.3.2 Nanodiamonds as a drug delivery carrier 
The requirements for drug delivery systems including biocompatibility, ease of 
attachment to different drugs or molecules, and dispersability, are all met by ND. In 
addition, ND allow the combination of drug delivery with imaging for assessment of 
delivery efficacy. The high loading capacity of ND is due to its large surface area; thus, it 
provides higher concentrations of these loads to be delivered. Li et al. (2010) reported 
that an anticancer drug conjugated with ND had a higher efficacy as compared to the 
drug alone (Li et al. 2010). Fluorescent ND were coated with a polymer shell and 
conjugated with cyclic RGD peptide and were shown to selectively target glioblastoma 
cells with high internalization efficacy (Slegerova et al. 2015). Protein functionalized-ND 
were used to deliver bone morphogenetic proteins to osteoblast progenitor cells to 
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promote bone formation (Moore et al. 2013). This study showed that the delivery system 
enhanced bone cell proliferation and differentiation. A short peptide-functionalized ND 
(DGEA-ND) and loaded with doxorubicin (DOX) was shown to successfully target bone 
metastatic prostate cancer cells in vitro which are known to over express α2β1 integrins 
during metastasis, and caused much higher cell death with higher specificity as compared 
to DOX alone, even at lower drug doses (Salaam et al. 2014). PEGylated ND loaded with 
DOX were shown to deliver the drug into human liver cancer cells in vitro with enhanced 
DOX uptake and a slow and sustained release of the drug (Wang D et al. 2013). DOX-
ND complex was also tested in mouse models of liver cancer and mammary cancer and 
revealed an enhanced cancer inhibition establishing a very promising foundation for ND-
based drug delivery systems (Figure 1.5) (Chow et al. 2011). These studies and many 
others, confirmed that the use of ND as a drug delivery vehicle enhances drug efficacy, 
allows sustained release of the drug, reduces side effects, and decreases toxicity and 
high drug doses.  
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Figure 1.5: ND-DOX complex inhibits tumor growth. Mammary carcinoma mouse model 
was injected by tail with PBS, DOX, or NDX (ND-DOX complex). Excised tumors from 
treated mice showed that ND-DOX complex treatment efficacy is much higher than the 
other treatments. From (Chow et al. 2011. Nanodiamond therapeutic delivery agents 
mediate enhanced chemoresistant tumor treatment. Science translational medicine. 
3(73):73ra21). Reprinted with permission from AAAS.  
 
 
1.3.3 Tissue engineering and surgical implants  
Restoration of damaged tissues is a core aim in the field of tissue engineering and 
regenerative medicine. In this field, ND can deliver growth factors to enhance cell 
proliferation (Moore et al. 2013), provide mechanical support for cells to grow on, and can 
be used as coatings of implantable medical devices. The superior features of ND such as 
chemical stability and hardness, presented ND as a preferred candidate for surgical 
implant coatings. Diamond-like carbon coatings were shown to enhance wear resistance 
and reduce the release of metal ions from orthopedic and dental implants (Gutensohn et 
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al. 2000; Roy and Lee 2007; Catledge et al. 2013). In a recent wear simulation study, two 
diamond surfaces (Convex and concave) produced by chemical vapor deposition of ND 
and after 5 million cycles of rotations of the diamond-on-diamond, showed that the ND 
surfaces remained intact and uniform thereby protecting the underlaying metal (Baker et 
al. 2016). This study verify that ND deposition improves the longevity of joint replacement 
devices as compared to existing devices. Another study suggested the addition of ND to 
Mg-based biodegradable implants to reduce corrosion rate of the implant (Gong et al. 
2015). Authors reported high cell viability and healthy cell morphology of cells grown in 
contact of Mg-ND composite. Investigation on the effect of various surface features of ND 
on osteoblast adhesion and proliferation reported that these features can be controlled to 
support or inhibit bone growth in different regions of an orthopedic implant (Yang et al. 
2009).  
In addition to implants coatings, Zhang and co-workers (2011) produced a poly L-
lactic acid (PLLA)-ND composite bone scaffold material for bone tissue engineering 
(Zhang et al. 2011). In their work, the PLLA-ND composite provided improved mechanical 
property, bright fluorescent to monitor bone re-growth, and options to load drugs. They 
also suggested the use of this composite as a surgical tool such as fixation devices 
(Zhang et al. 2011). A recent study on ND-based scaffolds showed that functionalized ND 
improve characteristics of bone implants and vascularization within bone substituents 
(Wu et al. 2017). Another study investigated the potential of cellulose-nanodiamond 
composites for bone tissue regeneration and showed that this composite can serve as a 
biointerface promoting cell adhesion, proliferation, and differentiation of bone cells (Vega-
Figueroa et al. 2017).   
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All the above-mentioned studies, and many others, showed the advantages of 
using ND in several biomedical applications (Zhu et al. 2012; Turcheniuk and Mochalin 
2017). However, introduction of ND into the body allows these particles to interact with 
other tissues and organs and hence, may affect or interfere with normal biological 
processes. The system that is responsible for discrimination between self/nonself and 
perform sequential reactions to eliminate any hazard is the immune system. Any foreign 
particle or pathogen enter the body is expected to encounter components of this system.  
 
1.4 The vertebrate immune system 
The functions of the immune system are essential for the body’s homeostasis, 
survival and health. Immune cells are generated from pluripotent hematopoietic stem cells 
(HSCs). These cells can self-renew and differentiate into the common lymphoid 
progenitor or the common myeloid progenitor (Figure 1.6). The common lymphoid 
progenitor cells further differentiate into the different lymphocytes; B lymphocytes (B 
cells), T cells, natural killer cells (NK), and the NK-T cells (Chaplin 2010). The common 
myeloid progenitor cells go through successive differentiation steps to generate 
megakaryocytes (which produces thrombocytes, platelets), erythrocytes (red blood cells), 
mast cells, granulocytes (neutrophils, basophils, and eosinophil), and monocytes (which 
can differentiate into macrophages or dendritic cells). After differentiation in the bone 
marrow, these cells are released to the blood and other tissues to perform their 
specialized functions. 
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Figure 1.6: Differentiation of hematopoietic stem cells into the different types of blood 
cells. 
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The immune system is composed of two arms, innate and adaptive immunity, 
which coordinate together to provide protection against invading pathogens, cancer cells, 
toxins, and clearance of dead cells and self-proteins, as well as for tissue remodeling and 
wound healing. The innate immunity initiates the immune response and activates the 
adaptive immune component to control any invading threat. Innate immunity is the non-
specific, early response (within hours) while the adaptive immunity can take days to 
develop the highly specific responses (late response). Thus, the innate immune cells can 
keep the infection in check if not being able to eliminate it, until the more specialized 
adaptive responses are activated. 
 
1.4.1 Antigen presentation 
The first signals for the initiation of an immune response are produced mainly by 
the cells that are usually present at the barriers interacting with the outer, or inner, 
environment. Professional antigen-presenting cells (APC) are macrophages, dendritic 
cells, and B cells but other cell types can also participate in antigen presentation during 
infection (Murphy 2011). These cells can recognize, engulf, process, and present 
antigens on their surfaces for T cells (Figure 1.7). Each of these steps is highly regulated 
and requires participation of many APC’s components at different levels in the immune 
response.  
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Figure 1.7: Antigen presentation by macrophages. Starts with recognition (1) where 
surface receptors recognize then bind to the pathogen or other components followed by 
internalization (2). The internalized endosome starts acidification (3) by decreasing the 
pH and fusing with or becoming lysosomes. The proteolytic enzymes along with reactive 
species help degrade (4) the pathogen into small peptides. These small peptides are then 
loaded onto the MHC-II molecules (5) and directed to the cell surface where they can be 
presented (6) and recognized by T cell’s receptors.   
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Antigen recognition involves interactions between innate immune cell pattern 
recognition receptors (PRR) and the foreign substances known as pathogen-associated 
molecular patterns (PAMPs), or with the damage-associated molecular patterns 
(DAMPs). The PRR are localized on the cell membrane to detect extracellular patterns, 
also in the endosomal/lysosomal membrane to detect patterns in the endocytosed 
materials, and in the cytosol recognizing the intracellular pathogens and their 
components. They can also be secreted to the extracellular environment to detect 
extracellular pathogens. These receptors provide an initial discrimination between self 
and nonself (Murphy 2011).  
Toll-like receptors (TLRs) are membrane-bound receptors (expressed on the cell 
surface membrane or in the endosomal membrane), that recognize different pathogenic 
patterns such as lipoproteins, lipopolysaccharides (LPS), and nucleic acids. Other 
membrane-bound PRRs such as C-type lectin receptors (CLRs), recognize other 
pathogenic components such as mannose, fucose, and glucans that are present on many 
pathogens. The cytosolic PRRs such as nucleotide oligomerization (NOD)-like receptors 
(NLRs), recognize peptidoglycans and are involved in regulation of inflammation. Certain 
stimuli can induce oligomerization of NLRs into a caspase 1-activating scaffold called 
inflammasome (Guo et al. 2015).  
After recognition, these cells can internalize the pathogen (if it is still in the 
extracellular matrix), start the degradation process, and carry out presentation and 
initiation of signaling pathway cascades that are essential for host defense. Internalization 
of pathogens can happen in a specific or non-specific manner depending on the type (and 
size) of the internalized component (Malhotra et al. 2011). Endocytic pathways include 
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several diverse mechanisms by which different cells use to internalize nutrients, growth 
factors, hormones, antibodies, antigens, or extracellular particles and fluids (Figure 1.8). 
These pathways are essential for the cell to survive and to respond to the external signals.  
 
 
 
Figure 1.8: Endocytic pathways include phagocytosis and pinocytosis. There are different 
classifications for the endocytic pathways based on size of the cargo or vesicle or based 
on the dependence of the pathway on specific proteins. (Modified from Mayor and Pagano 
2007; Murphy 2011).   
 
 
Phagocytosis is a process by which professional phagocytic cells such as 
monocytes/macrophages, engulf large (>200 nm and up to 10 µm) pathogens and 
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particles or remnants of dead cells (Conner and Schmid 2003; Malhotra et al. 2011). This 
process is highly regulated, it involves recognition by cell-surface receptors such as the 
Fc receptor that recognizes the antigen-coated pathogens leading to the activation of the 
cell’s inflammatory response. Phagocytosis is a crucial process not only for immune 
response, but also for clearing damaged tissues and during development without 
activation of inflammatory responses (Conner and Schmid 2003). 
Unlike phagocytosis which is primarily associated with phagocytes, the other 
endocytic pathways (collectively called pinocytosis) occur in all immune or non-immune 
cell types. Pinocytosis, also known as fluid-phase endocytosis, includes 
macropinocytosis, clathrin-mediated, caveolae-mediated, and clathrin-and-caveolae-
independent endocytosis. These endocytic pathways engulf smaller particles (50-200 
nm) along with extracellular fluids and are referred to as “cell drinking” while phagocytosis 
which internalize larger particles (like a whole bacterium or a dead cell) is called “cell 
eating” (Malhotra et al. 2011). Phagocytosis and macropinocytosis (in addition to some 
other clathrin-and-caveolae-independent pinocytosis) are actin-dependent pathways that 
require rearrangement of cytoskeletal actin filaments to form the membrane 
extensions/invaginations (Mayor and Pagano 2007). The other pinocytosis mechanisms 
have smaller vesicle sizes where the plasma membrane invaginates to form a bud coated 
or un-coated with specialized proteins.  
After internalization, the fate of internalized vesicle and its content depends on the 
endocytic pathway used. In the case of internalized pathogens or their components, these 
vesicles fuse with organelles in the endocytic pathway which contain proteolytic enzymes 
and a very low pH (high acidity). The early endosome starts to acidify by pumping more 
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H+ ions to their lumen to become late endosomes and then, lysosomes. In APCs, the 
degraded content usually contains many antigens that are loaded on the major 
histocompatibility complex class II (MHC-II) and displayed on the cell surface. T cell 
receptors (TCR) can only recognize the antigen bounded by MHC-II but not the free 
antigens, which is a crucial process for T cells activation. Also, TCR are highly specific 
for the antigens they bind to, unlike the less specific receptors on innate immune cells 
surfaces.  
 
1.4.2 Macrophages  
In addition to their role in antigen presentation (Figure 1.7), macrophages play 
crucial roles: in development; initiation of the immune response and its regulation; 
ingestion and killing of microbes; in the clearance of dead cells and cell debris; and in the 
repair of damaged tissues by promoting angiogenesis and fibrosis (Abbas 2015). 
Macrophages are found in almost all tissues of the body and they represent the first line 
of defense in innate immunity. Different subsets of macrophages are tissue-resident 
macrophages (Table 1.1), such as alveolar (dust cells) macrophages in the lung, Kupffer 
cells in the liver, microglia in the central nervous system, sinusoidal cells in the spleen, 
and Langerhans cells of the skin (Davies and Taylor 2015; Davies et al. 2013; Abbas 
2015). Each type of tissue-resident macrophages has distinct features and roles and 
respond differently to extracellular signals due to the tissue-specific environment and 
epigenetic effects (Davies and Taylor 2015).  
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Table 1.1: Tissue-resident macrophages. Reprinted, with modification, by permission 
from Macmillan Publishers Ltd: [Nature Immunology] (Davies et al. 2013), copyright 
(2013). 
Tissue  Cell type  Function  
Lung  Alveolar cells Immune surveillance and homeostatic regulation of tissue 
function  
Liver Kupffer Clearance of microorganisms, aged erythrocytes, and 
cell debris from the blood 
Central 
nervous 
system  
Microglia  Involved in frontline immune surveillance, removal of 
dead neurons and synaptic remodeling. 
Spleen  Sinusoidal 
cells 
Erythrocyte clearance and iron metabolism 
Skin Langerhans Interaction with T lymphocytes 
 
 
Monocytes migrate from the blood to tissues and differentiate into macrophages 
which are activated in response to a wide range of pathogens and host mediators. 
Activated macrophages usually migrate from the site of infection to the draining lymph 
nodes where they participate in antigen presentation (Bellingan et al. 1996). 
Macrophages are dynamic because they can respond to and acquire different activation 
states depending on the stimulus, tissue distribution, and their parent monocytes (Benoit 
et al. 2008). One of the main hallmarks of macrophages is their remarkable plasticity and 
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ability to differentiate into different populations/phenotypes. In fact, it was suggested that 
the number of different macrophages populations may be as diverse as the number of 
the distinct stimuli that activated them (Mosser and Zhang 2008).  
There are different ways to classify macrophages populations but in general, they 
are classified broadly into M1 and M2 (classically activated and alternatively activated, 
respectively) macrophages to mimic the Th1 and Th2 classification of T cells. Classically 
activated macrophages are stimulated by microbial components such as LPS, or by 
products of activated T cells such as interferon gamma (IFN γ), to become more efficient 
at killing microbes and secrete many pro-inflammatory cytokines and chemokines (Figure 
1.9). On the other hand, alternative activation is stimulated by other types of stimuli such 
as interleukin (IL) 4 and IL 13 to promote tissue repair and remodeling and secrete anti-
inflammatory cytokines and chemokines. More recent studies explored the heterogeneity 
of the M2 macrophages and sub-classified them into M2a, M2b, M2c, and M2d to cover 
a range of stimuli that induces the anti-inflammatory effects (Roszer 2015). 
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Figure 1.9: Activation of macrophages. M1 macrophages produce pro-inflammatory 
cytokines and chemokines to induce inflammation and recruitment of other immune cells. 
M2 macrophages produce anti-inflammatory cytokines and chemokines to inhibit 
inflammation, assess in healing, tissue repair and remodeling processes. The M2 
macrophages are sub-classified into M2a, M2b, M2c, and M2d based on the stimulation 
signals and production of cytokines, chemokines, and surface markers. Abbreviations, 
LPS: lipopolysaccharides, IFN: interferon, TNF: tumor necrosis factor, IL: interleukin, 
iNOS: inducible nitric oxide synthase, CCL: C-C motif ligand, CXCL: C-X-C motif ligand, 
CD, cluster of differentiation, MHC: major histocompatibility complex, TLR: Toll-like 
receptor, TGF: transforming growth factor, IC: immune complexes, GC: glucocorticoids, 
VEGF: vascular-endothelial growth factor. (Summarized from Gordon 2003; Benoit et al. 
2008; Roszer 2015; Colin 2014; Ferrante and Leibovich 2012; Martinez and Gordon 2014; 
Wang et al. 2010; da Silva and Gordon 1999; Duluc et al. 2007).    
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1.5 Immune response to nanoparticles 
Nanoparticles are foreign materials to the body and hence, they might be 
recognized by immune cells, initiate an immune response, modulate functions of immune 
cells, or deplete them. Immunotoxicity is any negative effect on the immune cells’ viability, 
proliferation, differentiation, or function. Immunotoxicity can be induced by exposure to 
nanoparticles leading to detrimental effects on the immune system and the whole body 
(Wang X et al. 2013). Over stimulation of the immune function can lead to allergies and 
autoimmune diseases, and suppression of the immune function can lead to increased 
incidence and severity of infectious diseases (Ghoneum et al. 2014; Wang X et al. 2013; 
Mitchell et al. 2009). Therefore, the immune system is highly regulated at all levels and 
modulation of its function can affect the health and survival of all other systems in the 
body. 
Innate immune cells represent the fast, nonspecific, first responders to any foreign 
substance or organism and had been studied extensively in immunotoxicity studies of 
nanoparticles. Exposure of innate immune cells to titanium dioxide or silicon dioxide 
nanoparticles induced the formation of the inflammasome, production of the pro-
inflammatory cytokine IL1-β, and activation of caspase-1 (Yazdi et al. 2010). Similar 
effects were reported, in addition to the increased production of reactive oxygen species 
(ROS) upon exposure of innate immune cells to silver nanoparticles (Yang et al. 2012). 
Nanometer-sized titanium dioxide particles were also reported to induce production of 
cytokines and expression of costimulatory molecules on dendritic cells and subsequently 
led to the activation of the adaptive immunity by priming the activation and proliferation of 
naïve CD4+ T cells (Schanen et al. 2009). Carbon nanotubes were reported to activate 
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components of the complement system, which is part of the innate immunity, via classical 
and alternative activation pathways (Salvador-Morales et al. 2006). These and many 
other studies, showed that exposure of innate immune cells to nanoparticles can induce 
an inflammatory response and activate the adaptive immunity. 
Suppression of immune function has also been reported. Dutta et al. (2007) found 
a reduction in LPS-mediated response from mouse macrophages after exposure to 
carbon nanotubes (Dutta et al. 2007). In addition, Mitchell et al. (2009) reported a 
suppressed systemic immune function in response to inhaled carbon nanotubes (Mitchell 
et al. 2009). The effects of ND on immune cells may go in either direction, suppression 
or over stimulation, and thus need to be further evaluated.  
Safety/toxicity of a nanomaterial cannot be drawn from that of the bulk material. 
The small size of these materials allows them to enter cells and/or bring in toxic elements, 
interact directly with cells and biomolecules, or interfere with biological processes. 
Several studies showed that internalization and toxicity of nanomaterials are size-
dependent (Carlson et al. 2008; Manolova et al. 2008; Kunzmann et al. 2011; Tsai et al. 
2012). In addition to size, the shape may also affect phagocytosis of the nanomaterial 
and production of cytokines. Carbon nanotubes were found to cause frustrated 
phagocytosis and the release of pro-inflammatory cytokines and ROS in macrophages 
(Brown et al. 2007; Murphy et al. 2012). Charge and surface chemistries can be 
modulated during or after synthesis of the nanomaterial and by interactions with proteins 
and ions before they encounter cells which affect their toxicity (Choi et al. 2010; Kong et 
al. 2015).   
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1.5.1 Toxicity studies on ND  
In addition to their unique physical and chemical properties, NDs are described as 
a highly biocompatible material (Yu et al. 2005; Liu et al. 2007; Schrand, Dai et al. 2007; 
Schrand, Huang et al. 2007; Liu B et al. 2016). Yu and colleagues (2005) showed that 
the 100 nm-sized ND did not affect metabolic activity in human kidney cells significantly 
(Yu et al. 2005). Schrand et al. (2007) investigated the toxicity of ND of sizes 2-10 nm 
and showed that ND are nontoxic to a variety of cell types with no significant ROS 
production (Schrand, Huang et al. 2007). Similar in vitro studies with different cell types 
reported the minimal toxicity of ND as compared to other carbon-based nanoparticles 
(Schrand, Dai et al. 2007; Liu et al. 2007). A ND-based probe for nitric oxide detection 
showed low toxicity and favorable biocompatibility in human adenocarcinoma cell line (Liu 
B et al. 2016).   
In addition to the in vitro studies, several in vivo studies also investigated the 
toxicity of ND. Mohan et al. (2010) tested the ND toxicity by feeding or microinjecting of 
ND in C. elegans and reported that ND were nontoxic and did not cause any detectable 
stress to the worm (Mohan et al. 2010). Interactions of ND with blood and blood 
components did not affect oxygenation state of red blood cells and did not induced an 
immune response (Tsai et al 2016). Other studies of ND for in vivo imaging applications 
in mice and rats demonstrated the good biocompatibility of ND administered via various 
routes (Vaijayanthimala et al. 2012; Igarashi et al. 2012).  
However, the controversy about biocompatibility of ND persists. Dworak et al. 
(2014) reported that ND of a size <10 nm were cytotoxic; inhibited proliferation, and 
induced apoptosis in lymphocytes at concentrations of ≥50 µg/ml (Dworak et al. 2014). In 
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their work, DNA oxidative damage and changes in chromatin stability were observed even 
at very low ND concentrations (Dworak et al. 2014). Another study also reported a 
decrease in cell proliferation after treatment with ND (6-100 nm) at lower concentrations 
(50 µg/ml) and a reduction in cell proliferation and metabolic activity at higher 
concentrations (200 µg/ml) (Thomas et al. 2012). The study also showed that ND with 
variable sizes induced a reduction in cell viability but did not promote inflammation 
(Thomas et al. 2012). A recent in vivo study showed toxic effects of ND in zebrafish 
embryos model, increasing mortality rate in early stages and changes in morphological 
features of the developing embryos (Lin et al. 2016). The potential impacts of ND on the 
immune system are still not fully understood and further studies are needed to evaluate 
their potential immunotoxicity. 
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CHAPTER 2 
 
SPECIFIC AIMS 
Nanodiamonds (ND) are being tested for a wide range of biomedical applications. 
Although they are described as a non-toxic, biocompatible material, the controversy about 
their immunotoxicity persists. I hypothesized that ND may induce an immune response in 
macrophages, and can affect or interfere with their differentiation and normal functions 
such as endocytosis and initiation of an immune response to conventional threats. I aimed 
to investigate the effects of ND on murine macrophage-like cell line in addition to primary 
cells isolated from mouse bone marrow and differentiated into macrophages.  
Aim 1: Investigate the initial interactions between mouse macrophages and ND.  
1. Examining of ND uptake by mouse macrophages using the fluorescence 
microscopy. Two mouse macrophage types treated or untreated with ND and 
mounted under fluorescence microscope to detect ND internalization and changes 
in cells morphology.  
2. Define the subcellular localization of ND in cells using confocal microscopy. 
3. Quantitate ND uptake using flow cytometer for cells treated with different 
concentrations and at different time points.  
4. Determine the uptake pathways of ND using endocytic pathways inhibitors. 
5. Assess cell viability of cells treated with varying doses of ND and for varying 
treatment intervals directly after ND treatment and on day one, two, and three after 
treatment using the MTS assay. 
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6. Assess the percent of apoptotic cells after ND treatment.  
Aim 2: Determine the effects of ND on gene expression in macrophages.  
1. Use real time-quantitative polymerase chain reaction (RT-qPCR) to assess 
response of these cells to ND. I chose the immune markers, IL1β, IL4, IL6, 
IL10, IL12, TNFα, CXCL2, and CCL2, to assess the pro- and anti-
inflammatory cell response to ND. 
2. Confirm the RT-qPCR results using Enzyme-Linked Immunosorbent Assay 
(ELISA) to detect changes in IL1β, IL6, IL10, IL12, CCL2, and TNFα protein 
production. 
Aim 3: Determine the effects of ND on macrophage function and differentiation.  
1. Challenge the ND-treated and untreated cells with LPS to compare LPS-
mediated responses in macrophages using RT-qPCR. 
2. Assess the endocytic activity of ND-treated cells. Expose the ND-treated 
and untreated cells to fluorescently-labeled dextran particles to compare 
their ability to internalize the dextran particles using flow cytometer. 
3. Determine the effects of ND on differentiating bone marrow cells. Treat the 
isolated bone marrow cells with ND before they differentiate into 
macrophages, then assess the cell morphology and expression of 
macrophage surface markers (CD11b and F4/80). 
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
3.1 Nanodiamonds and cell culture  
Carboxylated, HPHT ND (COOH-ND), with average size of 100 nm, containing 
>900 NV/particle, and excitation/emission of 532/700 nm, were purchased (Adámas 
Nanotechnologies, Inc. Raleigh, NC), and were used as received without any further 
modifications. The ND were sonicated for 10-15 minutes in water bath sonicator before 
each use and suspended in complete growth media at concentrations 1-100 µg/ml.  
Murine monocytes/macrophage cell line, J774A.1, originally isolated from ascites 
of an adult female BALB/cN mouse with reticulum cell sarcoma (American Type Culture 
Collection, Manassas, VA), were maintained in Dulbecco's Modified Eagle's Medium 
(DMEM, Lonza, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, 
Gibco USA), 100 units/ml penicillin and 100 µg/ml streptomycin (Gibco) at 37°C in a 5% 
CO2 humidified incubator.  
Bone marrow derived macrophages (BMDMs) were isolated and differentiated 
directly or frozen as previously described with some modifications (Weischenfeldt and 
Porse 2008; Marim et al. 2010). Briefly, C57BL/6, CD-1, DBA/2J, or BALB/cJ, mice 1-4 
months old, were euthanized in CO2 chamber. Bone marrow cells of femurs and tibias 
were flushed with phosphate buffer saline (PBS), passed through a 40 µm cell strainer 
(Celltreat), centrifuged at 200 g for 5 minutes, and re-suspended in freezing media; 90% 
37 
 
 
 
 
FBS and 10% DMSO. One milliliter of the cell suspension was added into each cryotube 
and left in the -80 freezer for 24 hours before transferring into liquid nitrogen tank for later 
use. Mice femurs and tibias were obtained through tissue sharing from IACUC approved 
protocols (14-003, 14-007, 15-027, 16-016).   
To prepare the BMDM, fresh or frozen bone marrow cells were re-suspended in 
differentiation media; RPMI 1640 (Mediatech Manassas, VA) supplemented with 20% 
FBS, 100 units/ml penicillin, 100 µg/ml streptomycin and 10 ng/ml macrophage-colony 
stimulating factor (M-CSF, Biolegend, San Diego, CA). Cells incubated at 37°C in a 5% 
CO2 humidified incubator were fully differentiated after day 7 and were harvested by 
scraping or detachment with 5 mM EDTA/PBS, counted and plated with cultivation media 
(same constituent as differentiation media except for 10% FBS).  
The primary mouse bone marrow cells usually acquire the macrophage phenotype 
within 7 to 10 days after isolation under M-CSF induction (Wang C et al. 2013; 
Weischenfeldt and Porse 2008). To confirm the BMDM phenotype, antibodies to 
macrophage surface markers, CD11b and F4/80 (AbD Serotec®) were used. After 
differentiation, cells were harvested and re-suspended in flow buffer (1% bovine serum 
albumin, BSA, in PBS) with blocking antibody (CD 16/32) for 10 minutes. One microliter 
of each FITC-CD11b and PE-F4/80 were added and incubated in the dark at room 
temperature. After 30 minutes, cells were washed and re-suspended in 300 µl flow buffer 
for Fluorescence-activated cell sorting (FACS) analysis (BD FACSAriaTM cell sorter BD 
Biosciences San Jose, CA). 
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3.2 Cell viability assays 
Cell viability was assessed using the MTS viability assay (CellTiter 96® AQueous 
Non-Radioactive Cell Proliferation Assay, Promega). The MTS assay is a colorimetric 
method to determine the number of viable cells based on their ability to reduce the 
tetrazolium compound into a soluble formazan product. The absorbance measured at 490 
nm is proportional to the number of viable cells. To determine the optimum seeding 
density for macrophages, cells were plated at varying densities and a standard curve was 
generated. Cells were plated at 2-3 x 104 cells per well of a 96-well plate. After 24 hours, 
cells were incubated with different concentrations of ND and for different time intervals. 
The MTS reagent was added directly or after 1, 2, or 3 days after ND treatment. After 2-
4 hours, supernatants were transferred into new wells and the absorbance at 490 nm was 
measured using a plate reader (SpectraMax i3, Molecular devices). The cell viability was 
obtained by normalizing the absorbance of the ND-treated cells against the control, 
untreated cells, and expressed as percentage.  
The apoptosis assay kit was used to assess the percent of cells at the early 
apoptosis phase after ND treatment (CellEvent™ Caspase- 3/7 Green Flow Cytometry 
Assay Kit, Thermo Fisher). This kit consists of a green detection reagent which defines 
apoptotic cells based on the ability of activated caspase 3 and caspase 7 to cleave this 
reagent to emit a bright green fluorescence. Cells were plated at 105 cells/well in 6-well 
plates. After 24 hours, the cells were treated for another 24 hours with 10, 50, or 100 
µg/ml ND, with the untreated cells as a negative control, and 10 µM staurosporine (Sigma) 
or a 100 ng/ml LPS (Xaus et al. 2000) as positive controls. Harvested cells were 
suspended in flow buffer and the kit was used per the user manual except that the dead 
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cell stain (SYTOXTM AADvancedTM), the second component of this kit, was not used due 
to the interference from ND.  
 
3.3 ND uptake and subcellular localization  
To study the ND uptake with the microscope, J774A.1 and BMDM were plated on 
coverslips. After 24 hours, cells were treated with 50 µg/ml ND for another 24 hours, 
stained with DAPI, and examined with fluorescent microscopy (Olympus BX51) at 535-
50 nm excitation and 610-75 nm emission, and with confocal microscopy to determine 
their subcellular localization (Leica TCS SP8, Leica Microsystems).  
To quantitate ND uptake, cells were harvested and plated at 105 cell/well in 6-well 
plates. After 24 hours, cells were treated with different concentrations of ND and for 
different time points. Each sample was harvested, centrifuged for 5 minutes at 1000 RPM, 
and re-suspended in flow buffer before FACS analysis. 
The uptake pathways were investigated through the application of endocytic 
pathways inhibitors (Sigma). Each inhibitor was prepared and applied separately for 30 
minutes at 37°C, prior to the treatment of cells with ND. The fluorescence signals from 
cells pre-treated or untreated with each inhibitor were measured using FACS. The 
inhibitors that were used are summarized in table 3.1.  
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Table 3.1: Endocytic pathway inhibitors. 
Inhibitor  Pathway  Reference  Concentration  
Chlorpromazine 
hydrochloride 
Clathrin-dependent 
endocytosis 
Wang et al. 1993; 
Shamsul et al. 2010 
20 µg/ml 
Phenylarsine oxide  Clathrin and receptor-
mediated endocytosis 
Gibson et al. 1989; 
Cai et al. 2015 
0.5 µg/ml 
Methyl-beta-
cyclodextrin  
Caveolae and 
clathrin-dependent 
endocytosis 
Rodal et al. 1999; Li 
et al. 2014 
10 mM 
Nystatin  Caveolae/lipid raft 
dependent 
endocytosis 
Payne et al. 2007; 
Shamsul et al. 2010 
40 µg/ml 
5-(N-Ethyl-N-
isopropyl) 
amiloride; EIPA  
Macropinocytosis West et al. 1989; 
Gerondopoulos et al. 
2010 
66 µM 
Cytochalasin D  Actin-dependent 
endocytosis  
Sampath and Pollard 
1991 
6 µM 
 
 
3.4 Gene expression   
To assess the ability of ND to induce an inflammatory response in macrophages, 
cells were plated at 1-2 x 105 cell per well of a 12-well plate and incubated at 37°C, 5% 
CO2 for 24 hours. Fresh media were added and the ND were sonicated for 15 minutes 
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before addition. Cells were incubated for 4 hours with or without 50 μg/ml ND before total 
RNA isolation.  
LPS is a bacterial endotoxin localized in the outer layer of the membrane of gram-
negative bacteria, and is known to induce a strong inflammatory response in human and 
animals. To investigate the ability of ND-treated cells to respond to LPS stimulation, cells 
were plated as above and treated with or without ND (50 µg/ml for 4 hours), then with or 
without 10 ng/ml LPS (Sigma) for 3 hours. 
RNA extraction from ND or LPS-treated and untreated samples was performed in 
the plates using ISOLATE II RNA Mini Kit (Bioline USA) per the manufacturer instructions. 
Complimentary DNA (cDNA) was synthesized using SensiFAST™ cDNA synthesis kit 
(Bioline USA). Quality and quantity of RNA and cDNA were assessed with NanoVue (GE 
Healthcare). The cDNA was amplified using SensiFAST SYBR® Hi-ROX kit (Bioline USA) 
in a Bio Rad CFX Connect Real-Time PCR Detection System (BioRad, USA). Primers 
(IDT®) sequences were from previously published work (references and sequences are 
summarized in table 3.2). To confirm primers specificities and find expected amplicons 
sizes, each primer pair was checked with in silico PCR (https://genome.ucsc.edu/cgi-
bin/hgPcr), and the resulted sequence were aligned to the target gene in blast nucleotide 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch
&LINK_LOC=blasthome).   
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Table 3.2. RT-qPCR primers.  
Gene  Forward primer  Reverse primer  Reference  
GAPDH TAT GTC GTG GAG 
TCT ACT GGT 
GAG TTG TCA TAT TTC 
TCG T 
Osterholzer et al. 2011; 
Davis et al. 2013 
Actin TGG AAT CCT GTG 
GCA TCC ATG AAA C 
TAA AAC GCA GCT 
CAG TAA CAG TCC G 
Osterholzer et al. 2011 
IL1-β CAA CCA ACA AGT 
GAT ATT CTC CAT G 
GAT CCA CAC TCT 
CCA GCT GCA 
Martinon et al 2010 
IL 6 GAG GAT ACC ACT 
CCC AAC AGA CC 
AAG TGC ATC ATC 
GTT GTT CAT ACA 
Martinon et al 2010 
TNF α CCT GTA GCC CAC 
GTC GTA GC 
AGC AAT GAC TCC 
AAA GTA GAC C 
Osterholzer et al. 2011 
CCL2 CCC ACT CAC CTG 
CTG CTA CT 
TCT GGA CCC ATT 
CCT TCT TG 
Santoro et al. 2015 
CXCL2 CCA CTC TCA AGG 
GCG GTC AAA 
TAC GAT CCA GGC 
TTC CCG GGT 
Thomas et al. 2012 
iNOS TTT GCT TCC ATG CTA 
ATG CGA AAG 
GCT CTG TTG AGG 
TCT AAA GGC TCC G 
Osterholzer et al. 2011 
IL4 AAC GAG GTC ACA 
GGA GAA GG 
TCT GCA GCT CCA 
TGA GAA CA 
Liu T et al. 2016 
IL10 ATA ACT GCA CCC 
ACT TCC CA 
GGG CAT CAC TTC 
TAC CAG GT 
Liu T et al. 2016 
IL12 GAT GAC ATG GTG 
AAG ACG GC 
AGG CAC AGG GTC 
ATC ATC AA 
Liu T et al. 2016 
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The PCR reaction volumes were 20 μl/sample and the program was 2 minutes at 
95°C, then 40 cycles of 5 seconds at 95°C and 30 seconds at 60°C and the PCR products 
were assessed with the melt curves. Gene expression data were normalized to two 
housekeeping genes; Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β 
actin, and the fold change was determined using the ΔΔCT method. Briefly, the Δct value 
is obtained by normalizing the threshold cycle (ct) value of the target gene with that of the 
housekeeping genes which are known to have stable expression under a wide range of 
treatments, to compensate for differences in the amount of loaded DNA or RNA. The fold 
change in the gene expression is obtained by calculating the difference between the Δct 
of the treated sample and that of the control sample and raising the ΔΔct value to the 
base 2 (2-ΔΔct) because the PCR assumes an exponential increase in the number of 
copies of the original mRNA for each gene after each cycle.  
To assess the amount of secreted proteins after ND treatment, macrophages were 
plated at 106 cell/ml in 6-well plates. After 24 hours, ND (50 µg/ml) or LPS (10 ng/ml) were 
added with fresh media and incubated for another 24 hours. Cell culture supernatant was 
collected, centrifuged at 1500 RPM for 10 minutes at 4 °C, and stored at -80 until analyzed 
with ELISAs. Protein concentrations of IL1β, IL6, TNFα, CCL2, IL10, and IL12 were 
measured using a sandwich ELISA-based flow kit (LEGENDplexTM mouse inflammation 
panel, Biolegend®, San Diego, CA) according to the manufacturer instructions. 
 
3.5 Effects of ND on macrophages endocytic activity   
BMDM were plated at 105 cells/well in a 6-well plate and after 24 hours, cells were 
treated with 0, 10, 20, or 50 µg/ml ND. After 16 hours, cells were incubated with cascade 
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blue-labeled dextran particles (3000MW Invitrogen, Eugene OR) for 45 minutes, washed 
and re-suspended in flow buffer for FACS analysis.  
 
3.6 Differentiation of BMDM 
Bone marrow cells were isolated from femurs and tibias as above and 
differentiated into BMDM in differentiation media with or without 50 µg/ml ND for 7 days. 
The mature cells were investigated for changes in surface markers expression (CD11b 
and F4/80) and changes in shape or morphology. 
 
3.7 Statistical analysis 
Results are presented as the mean values ± standard error of the mean (SEM) of at 
least three independent experiments. Test for significant was performed using one way 
ANOVA for multiple comparison followed by Dunnet’s test.  P value < 0.05 was 
considered statistically significant. Statistical calculations were performed using IBM 
SPSS version 24. Statistical significant was assessed with student’s T test when 
comparing one treatment with one control.  
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CHAPTER 4 
  
RESULTS 
 
 4.1 Phenotypic characterization of BMDM 
 
 
 
Figure 4.1: Phenotypic characterization of BMDM. Flow cytometry analysis showing the 
expression of macrophages surface markers. More than %90 of cells expressed the two 
markers; CD11b and F4/80 on their surfaces. Results are the average from four 
independent experiments ± SEM. 
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Bone marrow cells were isolated from mice femurs and tibias and differentiated 
into BMDM for seven days under M-CSF induction. After day seven, cells were fully 
differentiated into macrophages and their phenotype was confirmed using antibodies 
against macrophage surface markers, CD11b and F4/80. The percent of cells expressing 
each or both surface markers were analyzed using FACS and are shown in Figure 4.1. 
More than 90% of cells expressed the two markers together on their surfaces which 
confirms the macrophage phenotype.  
 
4.2 Interactions of ND with macrophages 
Macrophages are professional phagocytes and thus, they engulf a wide range of 
foreign particles in addition to self, dead or infected cells or molecules. I found that upon 
exposure of macrophages to ND, these cells internalize the ND spontaneously. 
Microscopic images of J774A.1 and BMDM incubated with ND showed the uptake of ND 
by these cells (Figure 4.2). ND appear as dark spots in the bright field images with a red 
fluorescence in the TRITC channel. Images showed that the shape of the cell did not 
change dramatically due to ND treatment. ND-treated cells appeared to be larger in the 
microscopic images but on contrary, forward scatter (FSC) measurements in FACS 
analysis showed that the ND-treated cells size decreased in a time-and dose-dependent 
manner (Figure 4.3).  
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Figure 4.2: Fluorescent microscope images. J774A.1 (A) and BMDM (B) control and ND-
treated (50 µg/ml ND for 24 hours) images from top to bottom are bright field, DAPI, 
TRITC, and merged images.  
Control ND-treated 
A 
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Figure 4.2: Continued.   
B 
Control ND-treated 
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Figure 4.3: ND-treated cells decrease in size. BMDM were treated with 0, 10, 50, or 100 
µg/ml ND for 24 hours (A) or with 50 µg/ml ND for 0, 2, 4, 6, or 8 hours (B). The size of 
ND-treated cells (Forward scatter, FSC parameter in arbitrary units, AU) was assessed 
using FACS. The decrease was dose- and time-dependent. Results represent the 
average of at least 3 independent experiments ±SEM. 
A 
B 
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Other morphological features of ND-treated cells such as the cellular granularity, 
was also affected after ND treatment (Figure 4.4 A and B). Cells treated with different 
concentrations of ND and for different time intervals, showed an increase in granularity 
as measured with the side scatter (SSC) in flow analysis. The increase in granularity was 
dose- and time-dependent.  
 
 
 
Figure 4.4: Granularity of ND-treated cells. BMDM were treated with 0, 10, 50, or 100 
µg/ml ND for 24 hours (A) or with 50 µg/ml ND for 0, 2, 4, 6, or 8 hours (B). Cell granularity 
(SSC parameter) was assessed using FACS and the results shows a dose- and time-
dependent increase in cell’s granularity. Results represent the average of at least 3 
independent experiments ±SEM. 
 
A 
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Figure 4.4: Continued.  
 
 
Representative graphs showing changes in FSC and SSC of ND-treated or 
untreated cells are shown in Figure 4.5. Both FSC and SSC of cells changed after ND 
treatment but in opposite directions, the FSC decreased and the SSC increased with 
increasing ND doses.   
 
 
 
 
 
B 
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Figure 4.5: Effects of ND treatment on FSC and SSC parameters. Representative graphs 
of FACS analysis for cells treated with different concentrations of ND showed the increase 
in SSC (cell granularity) and decrease in FSC (cell size) with increasing ND concentration.  
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To define the sub-cellular localization of ND in macrophages, BMDM were 
incubated with ND (50 µg/ml) for 24 hours and the nuclei were stained with DAPI (Figure 
4.6). The confocal microscope images showed that the ND entered the cell and localized 
to the cytoplasm but did not enter to the nucleus.  
 
 
 
Figure 4.6: Confocal microscope images. BMDM treated with ND were imaged with 
confocal microscope to determine ND sub-cellular localization. DAPI staining was used 
to stain the nucleus. Image of bright field (top left), DAPI (top right), TRITC (bottom left), 
and merged (bottom right). ND entered to the cytoplasm but not into the nucleus.   
54 
 
 
 
 
4.3 Cell viability 
The MTT and MTS assays measure the metabolic activity of cells indicating the 
number of metabolically active, i.e. live cells, through their ability to reduce tetrazolium 
compounds into formazan. One important difference between the two assays is that the 
MTT assay produce insoluble formazan that accumulates inside cells and requires cell 
lysis to be released into the media before measuring the absorbance while the MTS 
produces a soluble formazan that is released directly into the media without the need for 
cell lysis. I started with the MTT assay but suspected that the ND might be contributing to 
the absorbance. Therefore, I measured the absorbance of ND-treated cells at different 
wavelengths before performing the assay (Figure 4.7). These wavelengths are used for 
the MTT assay (570 and 690 nm) and for the MTS assay (490 nm). The result show that 
the absorbance increased with increasing ND concentrations and hence, they can give 
false increase in cells activity.  
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Figure 4.7: Absorbance of ND-treated cells at different wavelengths. J774A.1 cells were 
treated with 0, 1, 10, 20, 50, or 100 µg/ml ND and the absorbance was measured at 570 
(A), 690 (B), and 490 (C) nm.  
A 
B 
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Figure 4.7: Continued.  
 
 
I switched to the MTS assay because this assay does not require lysing of cells so 
that the media containing the released formazan can be transferred into new wells 
(without cells) before measuring the absorbance to avoid ND interference. To confirm that 
transfer of the supernatant did not affect the validity of MTS absorbance readings, I 
performed an MTS assay using a different cell type (4T1 cells), and the absorbance was 
read before and after transferring supernatant into new wells (Figure 4.8). Results showed 
that the absorbance of the formazan-containing cell culture media is lower after 
transferring into new wells but that did not affect the overall proportion with cell density.    
C 
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Figure 4.8: Effect of cell culture supernatant transfer. Cells were plated at different 
densities and after performing an MTS assay, the absorbance of formazan-containing cell 
culture supernatant was measured at 490 nm before (A) and after (B) transferring into 
new plates. Each result is the average of four replicates ± SEM.  
A 
B 
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The MTS assay was used to assess metabolic activity of the two macrophage cell 
types after ND treatment. The optimum seeding density for macrophages was determined 
by plating cells at different densities and generation of the standard curve (Figure 4.9). 
The plating density that falls in the linear range of the standard curve graph and with 
absorbance readings less than 2 was chosen (between 5000 and 30,000 cells/well).  
 
 
 
Figure 4.9: MTS standard curve. BMDM were plated in 96-well plates at densities from 0 
to 80 thousand cell/well. Each result is the average of four replicates ± SEM. 
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The first set of MTS experiments used the J774A.1 cell line treated for 24 hours 
with different concentrations of ND (Figure 4.10 A). In these experiments, the MTS assay 
was performed directly after ND treatment and results showed a slight decrease in 
metabolic activity of ND-treated cells though, it was not significant statistically even with 
the higher doses used (up to 100 µg/ml). Next, BMDM were treated with different 
concentrations of ND and for different incubation times and left for two days before 
performing the MTS assay (Figure 4.10 B). MTS assay with BMDM did not show a 
significant difference between ND-treated and untreated cells except for two 
concentrations/time points. The first significant difference was with the 8 hours treatment 
with 100 µg/ml ND where there was a significant increase in metabolic activity. Second 
significant difference was with the 12 hours treatment with 10 µg/ml ND were there was 
a decrease in metabolic activity. Overall, I detected no consistent effect of ND treatment 
on cellular viability.  
 
 
 
60 
 
 
 
 
 
Figure 4.10: Cell viability assay of ND-treated cells. (A) J774A.1 treated with different 
doses of ND for 24 hours. (B) BMDM treated with different doses and time points, 2 days 
after ND treatment. One way ANOVA was not significant except for the 100 µg/ml ND 
treatment for 8 hours and 10 µg/ml ND for 12 hours. Results represent the optical density 
(OD) at 490 nm normalized to the OD of control cells averaged from at least three 
independent experiments each with four replicates ±SEM. 
A 
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Figure 4.10: Continued.   
 
 
Changes in cell metabolic activity may not accurately indicate cell health or death. 
Sometimes, the cell may undergo transient changes in metabolic activity temporarily upon 
exposure to certain conditions or treatments. Therefore, ND-treated and untreated cells 
were monitored for 1, 2 and 3 days after the ND treatment and the MTS assay was 
performed on each day. Results showed a reduction in the metabolic activity with 
increasing concentrations and days after incubation, although differences were not 
significant statistically even at high concentration (Figure 4.11).  
 
B 
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Figure 4.11: Cell viability assay 1, 2, and 3 days after ND treatment. MTS of J774A.1 at 
1, 2 and 3 days after a 24-hour ND treatment with different concentrations. One way 
ANOVA from three independent experiment, each with four replicates, was not significant. 
 
 
To further investigate cell viability, the apoptosis assay kit was used without adding 
the red dead cell stain of the kit (SYTOXTM AADvancedTM) because the ND fluorescence 
was measured at different channels and was found to be interfering with that of this stain 
(Figure 4.12). Results from the apoptosis assay can indicate the percent of cells having 
the activated caspase 3 and caspase 7 but cannot distinguish between cells that are at 
the early or late apoptotic or necrotic cell death.  
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Figure 4.12: Fluorescence of ND. BMDM were treated with different concentrations of 
ND (0, 10, 50, or 100 µg/ml ND), and the fluorescence signal was measured using FACS. 
Results showed that fluorescence of ND can be detected in different channels including 
APC-Cy7 (A), PE-Cy7 (B), and PerCP-Cy5.5 (C). Results represent average of at least 
three independent experiments ±SEM. 
A 
B 
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Figure 4.12: Continued.  
 
 
I evaluated the percent of dead cells in macrophages treated with different 
concentrations of ND (Figure 4.13), and results showed an increase in the percent of 
dead cells in the ND-treated samples as compared to control, untreated cells. However, 
this increase was not significant.  
 
 
C 
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Figure 4.13: Apoptosis assay. BMDM were treated with 10, 50, or 100 µg/ml ND for 24 
hours. Negative control is untreated cells and positive controls are 100 ng/ml LPS and 
20 µM staurosporine for 24 hours. Results are average ±SEM from four independent 
experiments. 
 
 
4.4 Quantitation of ND uptake and their internalization mechanism 
The bright red fluorescence of ND enabled the detection of ND uptake with the 
fluorescent microscope (Figure 4.2), and quantification of ND uptake by cells using FACS. 
To quantitate the uptake of ND by these cells, BMDM were incubated with varying doses 
and for varying incubation times. The fluorescence of ND was measured in the APC-Cy7 
channel (excitation 650 nm, emission 785 nm). Results showed an increase in 
66 
 
 
 
 
fluorescence intensities with increasing the ND concentration (Figure 4.14 A) or 
increasing the time of incubation (Figure 4.14 B).  
 
 
 
Figure 4.14: Quantification of ND uptake. FACS analysis of BMDM treated with 0, 10, 50, 
or 100 µg/ml ND for 24 hours (A) or with 50µg/ml ND for 0, 2, 4, 6, and 8 hours (B). 
Results represent average of the Mean fluorescence intensity (MFI) of cells in arbitrary 
unit ± SEM from three independent experiments. 
 
A 
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Figure 4.14: Continued. 
 
 
To determine the uptake pathway of ND by macrophages, BMDM were pre-treated 
with different endocytic pathways inhibitors before exposing them to ND and the 
fluorescence signals were quantified using FACS (Figure 4.15). The results showed a 
reduction in ND uptake by about 40% when pre-treated with cytochalasin D (CYTO). 
Cytochalasin D is a known inhibitor of actin-dependent endocytosis pathways (Sampath 
and Pollard 1991). Both phagocytosis and macropinocytosis (In addition to other 
endocytic pathways) are actin-dependent pathways (Figure 1.7). However, only a slight 
reduction in ND uptake (< 10%) was noted when pre-treating with 5-(N-Ethyl-N-isopropyl) 
amiloride (EIPA), an inhibitor of macropinocytosis through the inhibition of Na+/H+ 
exchangers (Gerondopoulos et al. 2010), which suggest that ND uptake was through 
B 
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phagocytosis more than macropinocytosis. In addition, the clathrin-dependent 
endocytosis inhibitor also reduced the ND uptake by about 20% which also show the 
involvement of clathrin pathway in the uptake of ND by these cells.     
 
 
 
Figure 4.15: Endocytic pathways. FACS results showing the uptake of ND by cells pre-
treated or untreated with endocytic pathways inhibitor. BMDM were pretreated with each 
inhibitor for 30 minutes before exposing them to ND. Abbreviations, CPZ: chlorpromazine 
hydrochloride, PHYN: phenylarsine oxide, MBC: methyl-beta-cyclodextrin, NYST: 
nystatin, EIPA: 5-(N-Ethyl-N-isopropyl) amiloride, CYTO: cytochalasin D.   
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4.5 Effects of ND on gene expression in macrophages 
Macrophages are known to respond to a wide range of stimuli. Their responses 
include expression of surface activation markers, changes in their phagocytic activity, and 
secretion of cytokines, chemokines, and adhesion molecules. These events require 
activation or suppression of the transcription of certain genes and the subsequent 
translation and further processing to produce functional proteins. The aim of the following 
experiments was to assess the inflammatory response of macrophages upon exposure 
to ND. Macrophages cell line, J774A.1 and BMDM were exposed to 50 µg/ml ND and 
total RNA was isolated, converted to cDNA, and followed by RT-qPCR.  
The output files from the thermal cycler contains the ct values for each target gene 
which represents the threshold cycle or the cycle at which the amount of DNA reached 
the threshold value. The amplification curves showed the ct value of each reaction 
including the non-template controls (NTCs) and the melt curves confirmed the amplicon 
size (Figure 4.16). Some reactions may show amplification in the NTC which may indicate 
a contamination specially if the ct value of NTC is low. However, that amplification could 
be from primer dimers and this can be confirmed from the melt curve graph. The melting 
temperature of primer dimers is usually low because of its small size while in cases where 
there is a peak at a higher temperature (close to the melting temperature of the target 
amplicon), this indicates a contamination and the results are not valid.     
When using the ΔΔct method to calculate the fold change, the ct value of the target 
gene is normalized to the ct value of the reference gene (or genes). These calculations 
give the Δct value for each gene in each sample. Next, the Δct value of each gene in the 
treated sample is compared to that in the control sample to find the fold change in gene 
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expression. The fold change that lies between 1 and -1 is not considered as a change in 
gene expression. Any fold change value above 2 or below -2 can be considered as a 
change but to determine if this change is significant, statistical tests are usually used to 
compare the fold change for each gene.   
 
 
 
Figure 4.16: RT-qPCR graphs. Representative graphs from RT-qPCR experiments 
showing the amplification of cDNA for a target gene with differential gene expression (A) 
and non-differential expression (B). Melt curves for the amplicon in the reaction may show 
a second peak at a lower temperature from primer dimers (C). RFU: Relative fluorescence 
unit.  
 
A 
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Figure 4.16: Continued.  
 
 
B 
C 
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I assessed the expression of inflammatory cytokines; IL1β, IL6, TNFα, and iNOS 
and chemokines; CXCL2, and CCL2 in both cell types at the mRNA level using RT-qPCR. 
In addition, BMDM were also assessed for IL4, IL10, and IL12 expression after ND 
treatment. Results showed differences in the response of the two cell types to ND (Figure 
4.17).  
 
 
 
Figure 4.17: Gene expression in macrophages in response to ND. Macrophage cell line, 
J774A.1 (A), and BMDM (B) exposed to 50 µg/ml ND for 6-7 hours and the total RNA 
was isolated, converted to cDNA, and used for the RT-qPCR. Results obtained using the 
ΔΔct method and represent the mean fold change averaged from three independent 
experiment ±SEM. Student’s T test was not significant for all the tested genes (P>0.05). 
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Figure 4.17: Continued.  
 
 
Expression of iNOS was upregulated in BMDM but was not detected in the 
J774A.1 cell line.  The macrophage cell line showed some upregulation in the pro-
inflammatory genes except for IL6 whereas BMDM showed downregulation in all genes 
except for TNFα, CXCL2, and CCL2 that were unaffected. However, changes in all genes 
expression were not significant statistically in the two cell types.  
To confirm the RT-qPCR results, protein concentrations of IL1β, IL6, TNFα, CCL2, 
IL10, and IL12, were assessed with ELISAs (Figure 4.18). Results showed no effect of 
ND treatment as compared to the negative control (untreated cells) and positive control 
(10 ng/ml LPS) except for CCL2 which was much higher in the ND-treated sample and 
IL1 β which was not detected in all samples.  
B 
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Figure 4.18: Cytokines ELISAs. BMDM were treated with or without 50 µg/ml ND or 10 
ng/ml LPS.  After 24 hours, media were replaced and cells were incubated for another 24 
hours before collecting the supernatant for ELISAs. Results showed no effect of ND 
treatment on the expression of the tested cytokines except for CCL2. Results are average 
of two replicates ± coefficient of variation (CV).   
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Figure 4.18: Continued. 
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Figure 4.18: Continued.  
 
 
4.6 Effects of ND on macrophage functions and differentiation 
Depending on the specific physical and chemical properties of the nanoparticle, 
essential cell functions can be influenced by nanoparticles. In the case of macrophages, 
the ability to endocytose and respond to known threats are important for the function of 
the immune system because they represent the first responding cells to initiate the 
immune response. I aimed to investigate the ability of ND-treated cells to respond to a 
highly potent immunogen, LPS, in a negative (suppression) or positive (enhancement) 
direction.  
Macrophages cell line and BMDM were pre-treated with 50 µg/ml ND for 4 hours 
before exposing them to 10 ng/ml LPS. Response of the ND-treated and untreated cells 
to LPS was assessed using RT-qPCR. No significant changes in the expression of the 
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target genes were found between the ND-treated and untreated cells (Figure 4.19). 
Although not significant, the ND-treated macrophage cell line showed more variable 
expression in IL1β, a slight increase in IL6 and CXCL2, and downregulation of CCL2 while 
the primary BMDM expression was somehow unaffected by ND treatment.       
 
 
 
Figure 4.19: Effects of ND treatment on macrophages response to LPS. RT-qPCR results 
showing gene expression of cytokines in J774A.1 cells (A) and BMDM (B). Cells were 
pretreated with 50 µg/ml ND for 4 hours before exposing them to LPS for 3 hours. The 
results represent the mean fold change ±SEM calculated by ΔΔct method and averaged 
from at least three independent experiments.  
 
A 
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Figure 4.19: Continued.  
 
 
Next, I studied the endocytic activity of ND-treated cells by exposing them to 
fluorescently-labeled dextran particles. The internalized dextran particles fluorescence 
was measured with FACS and compared with that in untreated cells. Results show that 
ND pre-treatment reduced the uptake of dextran particles significantly (p< 0.05) (Figure 
4.20). The reduction in cell internalization of dextran particle was irrespective to ND 
concentration, although the lowest uptake (and lowest P value, 0.019), was at the highest 
concentration used (50 µg/ml ND).  
  
B 
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Figure 4.20: Endocytic activity. ND-treated and untreated BMDM were exposed to ND 
for 16 hours before exposing them to dextran for 45 minutes and the fluorescence 
signal from cells was measured using FACS. MFI results represent the mean ±SEM 
from three independent experiments. One way ANOVA and Dunnett t for multiple 
comparisons were significant (p< 0.05).   
 
 
The myeloid progenitor cells reside in the bone marrow where they differentiate 
into different types of blood cells including monocytes which further differentiate into 
macrophages or dendritic cells (Figure 1.5). These cells have been used to prepare 
macrophages or dendritic cells to study their biology or for other investigations such as 
cytotoxicity studies. Many protocols have been used to prepare BMDM but in general, 
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these cells differentiate in culture under induction of M-CSF for 7 days. After 
differentiation, these cells are assessed usually for their expression of macrophage 
surface markers to confirm the macrophage phenotype.  
Differentiation of macrophages is an important process to produce functional 
macrophages in vivo. The effect of ND on the differentiating bone marrow cells has not 
been studied. I investigated the effects of ND on the differentiation of these cells when 
they are exposed early (on day one after isolation from the bone) before they fully 
differentiated into BMDM. I assessed the cells morphology and expression of 
macrophages surface markers (CD11b and F4/80). The cell morphology did not appear 
to be affected by ND treatment (Figure 4.21). The ND-treated cells internalized the ND 
and they were able to re-adhere and form the normal cell shape after harvesting and re-
culturing.  
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Figure 4.21: Microscopic images of BMDM differentiated in the presence of ND. Isolated 
bone marrow cells were exposed to 50 µg/ml ND and incubate for 7 days with 
differentiation media. Bright field images showing ND-treated (right) and untreated (left) 
cells. ND did not appear to alter cell’s morphology.  
  
   
To determine the effects of ND treatment on the ability of BMDM to express 
macrophage surface markers, ND-treated and untreated cells were stained with FITC-
CD11b and PE-F4/80 antibodies and assessed with FACS (Figure 4.22). Exposure of 
bone marrow cells to ND before differentiating them, did not affect the percent of cells 
expressing each surface marker (Figure 4.23 A), or the fraction double positive for the 
two markers (Figure 4.23 B). More than 90% of cells expressed each or both markers in 
the ND-treated or untreated cells. However, the fluorescence intensities were reduced 
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significantly (p value 0.042 for CD11b and 0.008 for F4/80) in the ND-treated cells (Figure 
4.24). These results indicate that the number of cells expressing the surface markers 
(CD11b, F4/80, or both) was not affected by ND treatment while the number of each 
marker per cell is reduced in the ND-treated cells.  
 
 
Figure 4.22 FACS graphs for determination of effects of ND on surface markers 
expression. Representative graphs from FACS analysis showing the percent of cells 
expressing macrophage surface markers, FITC-CD11b and PE-F4/80.  
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Figure 4.23: Expression of surface markers in ND-treated and untreated BMDM. Bone 
marrow cells were exposed to 50 µg/ml ND and differentiated into macrophages under 
M-CSF induction for 7 days. Expression of cell surface markers was assessed with FITC-
CD11b and PE-F4/40 antibodies. (A) Percent of cells expressing CD11b or F4/80. (B) 
Percent each cell population based on their surface markers.  
A 
B 
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Figure 4.24: Effects of ND on the number of surface markers expressed per cell. 
Results represent fold change in MFI as compared to unstained control from four 
independent experiments. * p<0.05.   
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CHAPTER 5 
  
DISCUSSION 
Utilization of ND for biomedical applications is highly attractive but requires 
extensive studies to investigate their potential impacts. The chemical inertness of these 
particles does not imply biological inertness and therefore, I aimed to investigate the 
effects of ND on two macrophage cell types, J774A.1 cell line and BMDM. My studies 
involved assessment of the direct effect of ND on the cell and potential impacts on basic 
macrophage immune functions. 
 
5.1 Primary cells and macrophage-like cell line 
The macrophage cell line is widely used for cytotoxicity studies; however, these 
cells have a high mutational rate and the continual subculture of these immortalized cells 
results in the loss of genes that are not required for their survival, yet, are essential for 
immune functions of the cell (Marim et al. 2010; Kaur and Dufour 2012). In addition, the 
scientific community recommend the use of primary cells to add confidence in the study 
results due to the misidentification of cell lines that has been highly reported and requires 
authentication (Almeida et al. 2016; Horbach and Halffman 2017). Significant differences 
between macrophage-like cell lines (Including J774A.1) and BMDM has been reported 
(Chamberlain et al. 2009). Therefore, primary mouse macrophages, BMDM, were used 
in my studies because they may better represent the normal macrophages and to confirm 
results from my studies with the cell line.  
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The primary cells were differentiated under M-CSF induction, and their phenotype 
was confirmed with antibodies against the macrophage surface markers, CD11b and 
F4/80 (Figure 4.1). Other sources for M-CSF can be used to induce differentiation of 
BMDM such as L-929 fibroblast conditioned medium (Weischenfeldt and Porse 2008; 
Chamberlain et al. 2009; Marim et al. 2010). The mouse cell line, L-929, secretes M-CSF 
into the culture media which is usually collected and used to promote maturation of 
macrophages. To avoid any variability in the M-CSF concentration, I used the 
recombinant protein instead of the L-929 conditioned media.   
 
5.2 Effects of ND on cell morphology  
Exposure of cells to nanoparticles may affect or interfere with vital processes in 
cells. The effect may show directly as changes in cells morphology, metabolic activity, 
viability, or apoptosis. I assessed the effect of ND on macrophage morphology and found 
that the shape of the cell did not change dramatically after ND treatment, nonetheless, 
these cells appeared to be larger in the microscopic images as compared to the untreated 
controls (Figure 4.2). However, ND-treated cells were smaller than untreated cells as 
measured with the FSC parameter in FACS analysis (Figure 4.3). The ND-treated cells 
looked darker in color due to the ND appearing as dark spots in cells while the control, 
untreated cells, are transparent and this may explain the large appearance of ND-treated 
cells in microscopic images.  
Macrophages usually increase in size in response to stimuli such as LPS (Saxena 
et al. 2003; Pi et al. 2014). In addition to macrophages, HeLa cells and hepatocyte 
morphology were shown to be affected by ND treatment (Mytych et al. 2014; Mytych et 
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al. 2015). In these studies, both cell types were enlarged and showed cytotoxic effects 
such as inhibition of proliferation and oxidative stress after ND treatment. These toxic 
effects could be due to the smaller ND (<10 nm) that were used as well as differences 
between cell types. In general, smaller ND particles tend to exert more toxicity as 
compared to larger particles (Thomas et al. 2012; Keremidarska et al. 2014). Another 
study on detonation ND with different sizes showed size-specific and cell-type specific 
changes in morphology (Keremidarska et al. 2014). Detonation ND are prepared by 
detonation of graphene to produce smaller (4-5 nm) ND as compared to the larger HPHT-
ND (100 nm) used in my work but these primary sizes may not represent the actual size 
of ND interacting with cells due to the formation of ND aggregates. Smaller ND (4-6 nm) 
were also shown to increase the number of flattened peritoneal macrophages in 
microscopic images which was not detected in my experiments (Shkurupy et al. 2015). 
Cellular granularity was assessed with FACS and results show that the granularity 
increased in a time- and dose-dependent manner (Figure 4.4). Similar changes in 
granularity were reported for macrophages incubated with smaller ND while measuring 
the granularity from microscopic images (Mytych et al. 2015).  
 
5.3 Subcellular localization  
The confocal microscope uses optical sectioning (not physical sectioning) of cells 
to focus on a focal plan producing high resolution images (Inoué 2006). The focal plan 
passes through the cell at a specified depth and by moving in the Z plan, multiple images 
are taken at different focal plans to determine the presence or absence of ND in the 
nucleus. Confocal microscope images showed that ND are accumulated in the cytoplasm 
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but did not enter to the nuclei of macrophages (Figure 4.6). Other studies on 100 nm ND 
also showed the localization of ND in the cytoplasm but not in the nuclei of hepatocytes 
and lung cells, even at a much higher concentration (400 µg/ml) (Yu et al. 2005; Liu et al. 
2007). Nuclear entry may be determined by the size of nuclear pore complex (about 50 
nm). However, smaller (2-10 nm), detonation ND were also shown to be localized to the 
cytoplasm of HeLa cells (Li et al. 2010). It was important to determine the ability of 
nanoparticles to enter to the nucleus which depends primarily on their size and surface 
chemistry. Smaller particle (< 50 nm) with specific surface chemistry such as conjugated 
nuclear localization sequence (NLS), are more suitable to target the nucleus to deliver 
proteins or nucleic acids to the nucleus (Liu et al. 2007). Nevertheless, these smaller 
particles tend to exert more toxic effects by interfering with vital processes and 
biomolecules such as DNA and thus, larger particles are more suitable to avoid their 
entrance to the nucleus, while smaller particles are suitable to deliver drugs, proteins, or 
nucleic acids to the nucleus, depending on the intended application. 
 
5.4 Interference of ND with absorbance and fluorescence 
The ability of ND to absorb and emit light at different wavelengths is beneficial for 
different biomedical applications such as imaging and tracking. However, this can be 
problematic because it interferes with different assays to determine ND effects on cells. 
Different viability assays are colorimetric or fluorometric methods which relay on 
measuring the absorbance or fluorescence of the assay reagent to assess cytotoxicity.   
The absorbance of ND was measured at different wavelengths and I found that ND can 
absorb (Figure 4.7) and emit fluorescence signals (Figure 4.12) at different wavelengths.  
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The interference of ND was avoided in the MTS assay by transferring the 
formazan-containing cell culture supernatant into new wells before measuring the 
absorbance. Transfer of supernatant did not affect the overall proportion of absorbance 
among samples (Figure 4.8). To avoid ND interference with fluorescence signal from the 
apoptosis assay, the red-dead cell stain was not used and the percent of cells with a 
positive green signal that is associated with activated caspase 3/7, was used to determine 
the effects of ND on percent of cell death. 
In a study to investigate nanoparticles interference with toxicity assays, 24 different 
nanoparticles were shown to interfere with optical measurements of assay reagents (Kroll 
et al. 2012). Interference of nanomaterial with assay reagent could also be due to other 
mechanisms. Carbon nanotubes have been shown to “fake” cytotoxic effect when 
assessed with the MTT assay but not with other viability assays (Worle-Knirsch et al. 
2006). The study showed that carbon nanotubes do not affect the enzymatic reaction but 
the insoluble formazan crystals are lumped with nanotubes inside cells. The author 
concluded that the effect of nanomaterials should be assessed with more than one 
viability assay to avoid any unknown interference with assay reagents.  
 
5.5 Cell viability  
The viability of cells treated with different concentrations of ND and for different 
time intervals was assessed using the MTS assay. Results showed a slight reduction, yet 
not significant, in the viability of the two cell types analyzed directly after the ND treatment 
or after 1, 2, or 3 days (Figures 4.10 and 4.11). The MTS or MTT assays, which is another 
variant of MTS, were used in several previous studies to assess the cytotoxicity of ND. 
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Lung A549 epithelial cells and HFL-1 fibroblasts were used to investigate the cytotoxicity 
of different sizes of ND using the MTT assay and showed that both the 5 and 100 nm ND-
treated cells did not differ from the control significantly with these two cell types (Chao et 
al. 2007; Liu et al. 2007). Other studies used the MTT assay for macrophages, 
neuroblastoma cells, keratinocytes and PC-12 cells treated with functionalized or 
unfunctionalized ND and showed that the viability of these cells was not reduced by ND 
treatment (Schrand, Huang et al. 2007; Huang K et al. 2017). Another study by Schrand 
and coworkers (2007) showed a decrease in viability in macrophages, but not 
neuroblastoma cells, treated with ND (2-10 nm) at 50 µg/ml or higher (Schrand, Dai et al. 
2007). However, the authors concluded that ND are biocompatible compared to the other 
carbon-based nanomaterials tested.  
In these studies, and many others, the assay was performed directly or 48 hours 
after ND treatment. Evaluation of the cell metabolic activity directly after ND treatment 
may represent testing for acute cytotoxicity of ND. However, it can also be misleading 
because ND treatment may have a transient effect on cell metabolism which may return 
to its normal level with time. In addition, the toxic effects of the tested nanoparticle might 
be delayed until after being processed and interacting with cellular components. In my 
work, cell metabolic activity/viability was investigated in the two cell types directly after 
ND treatment, and after 1, 2, and 3 days after ND treatment. These experiments also 
investigated the effects of increasing the concentrations and treatment duration on the 
viability of macrophages. The MTS assay results suggest that these ND do not reduce 
cell viability significantly with the concentrations and treatment durations that were used. 
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The percent of dead cells in the ND-treated cells was assessed and compared to 
that of untreated cells as a negative control, and with the staurosporine- (10 µM) or LPS-
treated cells (100 ng/ml) as positive controls (Figure 4.13). The percent of dead cells in 
all ND-treated samples did not increase significantly. A previous study showed that 50 
and 100 µg/ml of small ND (<10 nm) were able to induce apoptotic cell death (Dworak et 
al. 2014). Their work also showed significant adverse effects on cell viability, proliferation, 
and DNA integrity in primary human lymphocytes. Prabhakar et al. (2017) suggested that 
cells couple endocytosis with exocytosis to eliminate the potential toxic effect of ND 
(Prabhakar et al. 2017). Different cells may have different endocytic or exocytic rates in 
addition to the uptake mechanism of different types of ND, which may explain 
inconsistency in results of ND toxicity studies.  
 
5.6 Quantification of the ND uptake and uptake mechanism  
Quantification of the ND uptake using FACS showed that the uptake of ND 
increased in a time- and dose-dependent manner (Figure 4.14). Other studies also 
showed the time- and dose-dependent uptake of different sizes of ND in different cell 
types. The fluorescence intensities of 5 and 100 nm ND were previously compared using 
flow cytometry and it was shown that the intensity of the smaller particles was higher than 
that of the larger ones at equal doses with lung epithelial cells (Liu et al. 2007). Their 
study suggested that the higher fluorescence intensity of the smaller particles is due to 
the higher surface-to-volume ratio of the smaller particles or higher uptake of these 
particles. The uptake of ND by cells also depends on the cell type. In a study comparing 
the uptake of a 100 nm ND by cancer and non-cancer human lung cells, both cell types 
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internalized the ND but the cancerous cells showed a much higher uptake of ND as 
compared to the non-cancerous cells (Perevedentseva, Hong et al. 2013). 
Nanoparticles are internalized into cells via different endocytic pathways 
depending on the nanoparticle characteristics and on the cell type being tested (Iversen 
et al. 2011). It is important to understand the mechanism of uptake to understand the 
possible fate of the nanoparticles inside the cell and their effects. Application of the 
endocytic pathways inhibitors showed that the ND uptake is mostly through an actin-
dependent (about 40%) and clathrin-dependent (about 20%) endocytosis (Figure 4.15). 
Macrophages are professional phagocytes and thus, they can phagocytose small and 
large (Up to 10 µm) particles, but this does not preclude the uptake through other 
pathways.  
Perevedentseva and coworkers (2013) showed that the uptake of 100 nm ND by 
lung adenocarcinoma cells and human bronchial epithelial cells was predominantly via 
clathrin-dependent endocytosis (Perevedentseva, Hong et al. 2013). Even though they 
used similar ND (100 nm), cell types were not like my cells and thus, this shows that 
different cells may use different uptake pathways to internalize ND. Another study also 
showed clathrin-dependent endocytosis of 140 nm ND by HeLa cells and fibroblastoid 
cells, but they also reported the involvement of actin filaments in the uptake process 
(Vaijayanthimala et al. 2009).  
A recent study showed that internalization of 100 nm ND by RAW 264.7 
macrophages was inhibited by about 23% by clathrin pathway inhibitor which is close to 
my findings for this inhibitor (Huang K et al. 2017). However, they did not find an effect of 
the actin inhibitor on ND internalization although they used a higher concentration of this 
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inhibitor (10 µg/ml compared to 6 µg/ml that I used). That study suggested clathrin-
dependent endocytosis but not phagocytosis. These inhibitors are selective but not 
specific for any endocytic pathway and can still interfere with the other pathways. For 
example, actin is known to be required for clathrin-dependent endocytosis so inhibition of 
actin should affect the clathrin pathway (Kaksonen et al. 2006; Dutta and Donaldson 
2012). In addition, the efficacy of these inhibitors varies in different cell types which can 
affect the results for determining the endocytic pathway of ND internalization.  
The specific properties of ND in addition to the route by which ND are introduced 
to the body, affect their biodistribution and fate in the body. An in vivo study reported that 
about 60% of the 50 nm ND accumulated in the mouse liver, 0.5 hour after intravenous 
injection and lesser percentages were in the lung and spleen (Yuan et al. 2009). The 
study also showed that the values remained the same after 28 days and trace amounts 
of ND were detectable in urine and feces. Another study reported that the intradermally 
injected 100 nm ND are drained from injection sites by macrophages and accumulated in 
axillary lymph nodes (Vaijayanthimala et al. 2012). Su et al. (2017) used 100 nm ND to 
label human mesenchymal stem cells and quantitatively tracked the labeled cells or ND 
alone in miniature pigs and reported that most of the ND and ND-labeled cells 
accumulated in lungs after 48 hours of intravenous injection and lesser amounts in the 
liver then the spleen (Su et al. 2017). These studies showed the biodistribution of the 50 
and 100 nm ND after intravenous and intradermal injections but it is still unknown whether 
these organs are able to eliminate or degrade the ND. In addition, the long-term effect of 
these entrapped particles is yet to be determined. 
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5.7 Effects of ND on gene expression  
I investigated the inflammatory response in ND-treated macrophages at the mRNA 
level using RT-qPCRs of cytokines and chemokines. ND treatment (50 µg//ml for 6-7 
hours) did not induce a significant change in the expression of the tested cytokines 
although some differences were noted in the expression between the two cell types 
(Figure 4.17). The interleukin (IL) family member, IL1β, is a pro-inflammatory cytokine 
that is crucial for the inflammatory response and can affect almost all cell types in the 
body (Dinarello 1996). Therefore, secretion of the functional IL1β is strictly regulated and 
requires a priming step to induce expression of the pro-IL1β, which is an inactive 
precursor of IL1β, followed by further exposure to additional stimuli to induce its 
proteolytic cleavage by caspase 1 (Lopez-Castejon and Brough 2011). Activation of 
caspase 1 requires recruitment of the inflammasome which was shown to be formed in 
response to a range of nanoparticles; TiO2, SiO2, polystyrene, carbon nanotubes, carbon 
black, and silver nanoparticles (Yazdi et al. 2010; Lunov et al. 2011; Palomaki et al. 2011; 
Reisetter et al. 2011; Winter et al. 2011; Yang et al. 2012). These studies, and others, 
suggest that activation of inflammasome is a critical event in the immunotoxicity of 
nanoparticles which may worsen the immune response in subsequent exposures to 
pathogens (Wang X et al. 2013). 
The inflammasome is a multimeric protein which can form in innate immune cells 
in response to certain stimuli (Guo et al. 2015). Activation of the inflammasome is a pre-
requisite for the activation of IL1β which in turn, can activate other immune cells and the 
subsequent activation of TNFα, IL6, CCL2, and CXCL2 (Dinarello 1996; Brabcova et al. 
2014). The pro-inflammatory cytokine, TNFα, has central regulatory roles in the 
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inflammatory response and has been targeted in a range of inflammatory diseases 
(Bradley 2008). Most, if not all, inflammatory states have elevated levels of IL1, IL6, and 
TNFα (Scheller et al. 2011). IL6 can act as a pro or anti-inflammatory cytokine depending 
on its binding to the soluble or membrane-bond receptors, and it has roles in regulation 
of the transition from acute to chronic inflammation (Gabay 2006; Scheller et al. 2011). 
Chemokines such as CCL2 and CXCL2, are secreted by many cell types, but mainly by 
monocytes/macrophages in response to proinflammatory cytokines where they 
selectively recruit monocytes, neutrophils, and lymphocytes to the site of inflammation 
(Deshmane et al. 2009; Rouault et al. 2013). 
Previous studies investigated the response of different cells (other than 
macrophages), to ND. Human natural killer (NK) cells were shown to upregulate their 
expression of IFNγ but not TNFα, only in the presence of IL12 (Suarez-Kelly et al. 2017). 
Mytych et al. (2014) showed that ND (<10 nm) induced intracellular ROS production in 
total cell and in mitochondria of HeLa cells (Mytych et al. 2014). Intracellular ROS is an 
important signal for the activation of the inflammasome (Harijith et al. 2014). Secretion of 
cytokines were not altered in MSCs in response to ND treatment (Blaber et al. 2013).  
Few studies have investigated the inflammatory response of macrophages to ND. 
Small (2-8 nm) ND were reported to have no effect on the expression of IL6, TNFα, and 
iNOS in RAW 264.7 murine macrophages (Huang et al. 2008). Another study using 
different sizes of ND (6, 60, 100, 250, and 500 nm) to assess expression of IL1β, TNFα, 
CXCL2, CCL2, platelet-derived growth factor (PDGF), and VEGF at the mRNA level in 
RAW 264.7 cells reported that ND treatment caused a down regulation in the tested genes 
irrespective to particle size (Thomas et al. 2012). Human monocytes were shown to 
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increase TNFα expression but not IFNγ, in response to ND without displaying any 
increase in the expression of activation markers on their surfaces (Suarez-Kelly et al. 
2017).  Although I noted some upregulation in the inflammatory genes expression in 
J774A.1 cell line, my RT-qPCR results did not show any significant difference in gene 
expression in J774A.1 or BMDM which was not tested previously in these cell types. The 
difference in macrophage response to ND could be due to differences in the size or 
properties of the used ND or differences between cell types. My results are in agreement 
with a recent study that showed no significant production of pro-inflammatory cytokines 
in 100 nm ND-treated Raw 264.7 macrophages (Huang K et al. 2017).  
Although I did not find a significant upregulation in the expression of CCL2 in 
response to ND at the mRNA level, a significant increase was noted at the protein level 
(Figure 4.18). The stability of the mRNA or coupling the transcription with translation in 
addition to the time that it is required for this chemokine to be transcribed and translated 
into a functional protein, may explain the increased protein concentration but not the 
mRNA levels. This chemokine is involved in the recruitment of monocytes, neutrophils, 
and lymphocytes to the site of inflammation and stimulate the release of IL1 and IL6 from 
macrophages/monocytes (Deshmane et al. 2009; Rouault et al. 2013). This chemokine 
was shown to be downregulated after exposure of RAW 264.7 macrophages to 60 nm 
ND for 24 hours (Thomas et al. 2012). Differences between cell types and ND types might 
cause this inconsistency in the expression results of CCL2. The extreme hardness of ND 
suggest that these particles may not be susceptible to biodegradation, though, 
susceptibility of ND to biodegradation is still unknown (Bhattacharya et al. 2016). The 
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increased expression of CCL2 by macrophages could be due to the inability of these cells 
to degrade ND and thus, trying to recruit other cells to eliminate them.  
   
5.8 Effects of ND on macrophage response to LPS 
To assess the ability of ND-treated cells to respond to conventional immunogen, 
ND-treated and untreated cells were exposed to LPS, the TLR4 ligand, and their 
responses were compared with RT-qPCR. Both the ND-treated and untreated cells 
responded to the LPS with no significant difference between their responses (Figure 
4.19).  A study on the effects of gold nanoparticles on macrophage function showed that 
these particles inhibit the production of pro-inflammatory cytokines and attenuate the 
response of RAW264.7 and BMDM to CpG (TLR9 ligand) with some variations in the 
responses of the two cell types (Tsai et al. 2012). To my knowledge, the effects of ND on 
macrophages functions and more specifically, their response to LPS, has not been 
investigated. I found that ND-treated cells respond to LPS normally, like the untreated 
cells, at the concentration (50 µg/ml) and time of incubation (4 hours with ND then 3 hours 
with LPS) used. The effects of different ND, on functions of different cell types may vary 
and yet to be explored. In addition, other immune markers could be affected in 
macrophages exposed to ND and their responses to other immunogens could be affected 
after ND treatment.  
 
5.9 Effects of ND on macrophage endocytic activity  
Another cell function was also investigated. ND-treated and untreated 
macrophages were exposed to fluorescently-labeled dextran particles and the 
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internalized dextran was measured with FACS. The uptake of dextran was significantly 
reduced in ND-treated cells irrespective to the ND concentration (Figure 4.20). Kodali et 
al. (2013) showed that interactions of macrophages with amorphous silica or 
superparamagnetic iron oxide nanoparticles caused extensive differential gene 
expression in response to LPS and reduced the cells’ ability to phagocytose 
Streptococcus pneumoniae significantly (Kodali et al. 2013). Interestingly, the two 
nanoparticles did not cause direct cytotoxicity or production of pro-inflammatory 
cytokines; rather, they impaired the macrophages’ responses and ability to transition from 
the M1 to M2 phenotype (Kodali et al. 2013). Iron oxide nanoparticles did not induce the 
production of TNFα, IL6, or IL1β in primary human monocytes; nonetheless, they 
suppressed the LPS-induced production of the pro-inflammatory cytokines (Grosse et al. 
2016). Amino-functionalized polystyrene nanoparticles were shown to inhibit 
phagocytosis of E. coli in M1 and M2 macrophages and again, no reduction in cell viability 
or expression of M1 surface markers (Fuchs et al. 2016). Macrophages exposed to TiO2 
nanoparticles were reported to have lower chemotactic, phagocytic, and bactericidal 
activities with no cytotoxicity in these cells while inducing the expression of pro-
inflammatory cytokines and inhibition of M2 markers (Huang C et al. 2017). These studies 
showed that nanoparticles can impair the innate immune functions in macrophages or 
modulate their activation state but not necessarily cause cell death.  
The effects of ND on macrophages phagocytic or more generally, endocytic activity 
has not been studied. My results showed a significant reduction in the macrophages 
endocytic function with all the ND concentrations used. The mechanism by which these 
particles affect endocytosis in macrophages is yet to be investigated. A recent study on 
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the effect of ND on macrophage cell line, RAW 264.7, bactericidal activity showed that 
ND-treated macrophages were able to decrease the number of E. coli colonies and 
reported no effect of ND treatment (Huang K et al. 2017). However, that study did not 
investigate ND effects on other macrophage functions. 
 
5.10 Differentiation of BMDM in the presence of ND 
Effects of ND on differentiating bone marrow cells has not been studied and 
therefore, I exposed the isolate bone marrow cells to ND (50 µg/ml) and assessed their 
morphology and expression of the macrophage surface markers. The results showed that 
ND treatment did not affect the cell morphology or the percent of cells expressing the 
macrophage surface markers (Figures 4.21, 4.22, and 4.23). However, the number of the 
surface markers on each cell was reduced significantly (Figure 4.24). These results 
suggest that most of the cells were able to acquire the macrophage phenotype (were 
double positive for the two markers, CD11b and F4/80), while showing a reduction in the 
expression of these markers which may indicate some effects on macrophage function.     
The macrophage surface marker, CD11b, is a subunit of macrophage-1 antigen 
(Mac-1) which mediates cell adhesion, spreading and migration among other immune 
processes (Solovjov et al. 2005). Mac-1, also known as complement receptor 3 (CR3), 
can bind to inactive complement fragment 3 (iC3b) and is expressed on many leukocytes 
(Todd 1996). In addition to its roles in immune processes, CD11b has been used to 
identify macrophages when it is expressed along with F4/80 on the cell surface (Austyn 
and Gordon 1981; Weischenfeldt and Porse 2008). The reduction in the expression of 
100 
 
 
 
 
CD11b and F4/80 on macrophages may indicate an inhibition or attenuation of some 
immune functions such as migration and binding to complement components. 
Monocytes differentiate from myeloid progenitor cells in the bone marrow and 
leave to the blood where they circulate for days before they move to other tissues (Murphy 
2011). Upon injury or exposure to an immunogen, monocytes migrate from the blood into 
the injured tissue and differentiate into mature macrophages where they participate in the 
immune response. Immune cells, including macrophages, present at the injured or 
inflamed location secrete inflammatory cytokines and chemokines to recruit and activate 
other immune cells. Recruitment of immune cells through chemokine gradient to the site 
depends on the ability of the cell to express adhesion molecules on its surface to promote 
migration. Exposure of the cells to ND altered their ability of expressing these markers by 
reducing the number of each marker per cell and maybe other surface receptors or 
activation markers that would need further investigations. 
Studies on the effect of ND on immune cells function and differentiation have been 
elusive. Huang K et al. (2017) investigated the effect of HPHT ND (100 nm) on RAW 
264.7 macrophages bactericidal function (Huang K et al. 2017). They found that the 
number of bacterial colonies formed in the ND-treated sample was similar to that in the 
control cells. The authors concluded that these ND are biocompatible and do not affect 
macrophage bactericidal function (Huang K et al. 2017).  
A recent study on the effects of nanoparticles on human THP-1 macrophages 
function showed that phagocytosis of opsonized beads was decreased while 
phagocytosis of unopsonized beads was increased by SiO2, FeO3, CeO2, TiO2, and 
Ag/SiO2 nanoparticles treatments, while ZnO reduced both (deLoid et al. 2016). I suggest 
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that the reduction in phagocytosis of the opsonized beads could be due to a reduction in 
the expression of complement receptors, such as Mac-1, or other surface receptors on 
these macrophages in response to nanoparticles. Comparative work with ND may reveal 
their effects on phagocytosis of opsonized and unopsonized particles. Another study 
showed that introduction of ND into chicken embryos led to a significant reduction in the 
vascularization of the heart and the density of branched vessels (Wierzbicki et al. 2013). 
Their work showed that ND can affect differentiation through downregulation of basic 
fibroblast growth factor during embryogenesis leading to a reduction in the formation of 
new blood vessels. This confirms that ND can affect the ability of cells to express certain 
genes during differentiation which is in agreement of my finding regarding the ability of 
macrophages to express CD11b and F4/80 during differentiation after ND treatment. On 
the other hand, ND were reported to have no negative effects on embryonic development 
of C. elegans (Mohan et al. 2010). Reduction in CD11b and F4/80 in BMDM could be due 
to ND interfering with signaling cascades that usually induce the expression of these 
markers. Bone marrow cells are usually incubated with M-CSF to differentiate into BMDM 
under normal culture conditions. Exposure of these cells to ND before they differentiate 
into BMDM might affect their responses to M-CSF induction, which is the driving factor 
towards macrophage differentiation.  
Several studies investigated the cytotoxicity of ND using different viability assays 
and most of these reported ND biocompatibility in different cell types. However, fewer 
studies focused on the effects of ND on immune cell functions. The effect of ND on 
differentiating cells may vary depending on the type of ND and the model system used. 
Meanwhile, their effect on differentiating bone marrow cells has not been investigated. 
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The above-mentioned studies showed an inconsistency in results which could be due to 
the nature of the tested ND in addition to differences in the animal model or cell type. With 
the wide range of ND sizes, shapes, surface chemistry and charge, it is impossible to 
generalize the toxic/nontoxic effect of different types of ND.  
 
5.11 Size-dependent effects   
Nanoparticles are currently produced with different sizes of the material to find the 
suitable size for the intended application. The size-dependent toxicity of nanoparticles 
has been reported in several studies (Carlson et al. 2008; Manolova et al. 2008; 
Kunzmann et al. 2011; Tsai et al. 2012). Small ND (6-100 nm) has also been shown to 
induce toxic effects in different cell types (Thomas et al. 2012; Dworak et al. 2014; 
Keremidarska et al. 2014; Mytych et al. 2014; Mytych et al. 2015). In these studies, ND 
induced a reduction in metabolic activity and cell viability, inhibition of proliferation, DNA 
oxidative damage, or apoptosis among other toxic effects. On the other hand, other 
studies reported no toxic effects of 2-100 nm ND (Chao et al. 2007; Liu et al. 2007; 
Schrand, Huang et al. 2007; Huang K et al. 2017). Although it’s hard to generalize but, 
the 100 nm ND seems to be at the border between the toxic/nontoxic effects. Small ND 
(such as 5 nm) have higher surface-to-volume ratio than the larger particles (100 nm) and 
they may have higher uptake by the same cell type at the same doses than the larger 
particles (Liu et al. 2007). These differences between smaller and larger particles may 
indicate more potential interactions of the smaller particles with biomolecules and 
processes and thus, more potential effects on cells.   
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Small (<10 nm) ND may enter the cell through endocytic or non-endocytic 
pathways (Passive transport or diffusion). Diffusing ND can spread in the cytoplasm while 
the endocytosed particles were shown to co-localize with endosomes/lysosomes (Huang 
K et al. 2017). The particle size of ND has not been linked with the ability of ND to enter 
to the nucleus although the smaller particles (<50 nm) can, theoretically, fit into the 
nuclear pore complex. Small (2-10 nm) and large (100 nm) ND were shown, in my work, 
and other studies to localize to the cytoplasm but not into the nucleus of different cell 
types (Yu et al. 2005; Liu et al. 2007; Liu et al. 2009; Li et al. 2010; Perevedentseva, Hong 
et al. 2013). This finding implies that any toxic effect from the small or large ND is not 
induced by direct interactions of ND with DNA or other nuclear components.  
The size of ND does not seem to be the factor that would determine whether ND 
will induce an inflammatory response in cells or not. The macrophage cell line RAW 264.7 
has been shown to assess the inflammatory response to ND and results showed that 
small (2-8 nm) ND did not affect the expression of inflammatory cytokines while varying 
sizes (6-500 nm) ND have been shown to downregulate the expression of these genes in 
the same cell line (Huang et al. 2008; Thomas et al. 2012). The different effect of ND in 
these macrophages could be due to differences in the type of ND used in these studies. 
In addition, the 100 nm ND did not affect the expression of inflammatory cytokine in that 
same cell line in a recent study which agrees with my results in J774A.1 and BMDM 
(Huang K et al. 2017).    
 
 
 
104 
 
 
 
 
CHAPTER 6 
 
CONCLUSION AND FUTURE WORK 
Utilization of ND in the biomedical field is gaining more interest with highly 
promising results for in vivo imaging and theragnostic applications. These applications 
require more in-depth investigations on the safety and interactions of ND with different 
cells and systems at the molecular level. I hypothesized that ND can affect macrophages 
and interfere with their functions and I aimed to study interactions of ND with these cells 
to better understand the potential impact of ND on the immune system. I found that ND 
do not affect the macrophages’ morphology or cell viability significantly. My results show 
that ND can interfere with MTT and MTS assay results due to the ability of ND to absorb 
light at different wavelengths. Fluorescence of ND is beneficial for ND tracking inside the 
cell and for imaging and quantification of ND uptake among others. However, this 
fluorescence can be problematic because it can interfere with fluorescence signals from 
other assays reagents such as the red-dead cell stain in the apoptosis assay kit. During 
my search for viability assays, all the assays I found were based on measuring 
absorbance or fluorescence signals of assay reagents to indicate cell viability. Therefore, 
care should be taken when interpreting colorimetric and fluorometric assays results 
because ND can give false positive signals which may be hard to avoid in such assays.  
The uptake of ND by macrophages via phagocytic and clathrin-dependent endocytosis, 
is time- and dose-dependent. These particles localize to the cytoplasm of macrophages 
without entering the nucleus or inducing an inflammatory response. Exposure of 
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macrophages to ND do not affect the expression of IL1β, IL4, IL6, IL10, IL12, TNFα, iNOS, 
CCL2, or CXCL2 at the mRNA level significantly. On the other hand, the chemokine CCL2 
was upregulated at the protein level. Exposure of macrophages to ND did not affect or 
interfere with their responses to LPS, at least, in the immune markers that were tested.  
However, the ability of macrophages to endocytose dextran particles was significantly 
reduced at high and low ND doses. In addition, pre-treatment of the isolated bone marrow 
cells with ND before they differentiate into BMDM did not cause changes in their 
morphology or the percent of cells expressing macrophage surface markers. 
Nonetheless, ND treatment reduced the number of surface markers (CD11b and F4/80) 
expressed per cell.  
My results suggest that ND are not cytotoxic to macrophages at the concentrations 
used. On the other hand, ND can interfere with macrophage functions and differentiation. 
Future work will investigate other cell functions such as the required steps for antigen 
presentation (Figure 1.7, recognition, internalization, acidification and fusion with 
lysosomes, degradation, and expression on MHC-II on cell surface), and explore the 
mechanisms by which ND are interfering with macrophages functions. The downstream 
effect of the reduction in endocytic activity and reduction in macrophages surface markers 
expression are yet to be determined. Response of these cells to other immunogens such 
as CpG (TLR9 ligand), might be affected by ND treatment and need to be studied. In 
addition, a more comprehensive study to evaluate gene expression patterns using a 
microarray or RNA sequencing of mRNA, may reveal changes in gene expression in ND-
treated cells which may affect vital biological or immunological pathways in these cells. 
ND with different sizes and surface chemistries may have different effects on 
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macrophages and should be studied. In addition, these particles may be internalized into 
macrophages through different endocytic pathways. Other approaches to determine the 
endocytic pathway include genetic blocking of specific genes or proteins to selectively 
block a specific pathway which would be more reliable than the use of the endocytic 
pathway inhibitors (Dutta and Donaldson 2012). Other than macrophages, interactions of 
ND with other immune cells and their effects on the expression of other immune mediators 
are also needed. Due to the key roles of macrophages in the immune system, I believe 
that the effects of ND on these cells will impact the overall immune system function. 
However, these effects could be different in the presence of other immune system 
components and therefor the impact of ND on the immune system should be investigated 
in animal models to better assess the immunocompatibility of ND. Previous in vivo study 
showed that macrophages drain ND (100 nm) from injection sites to the axillary lymph 
nodes (Vaijayanthimala et al. 2012). However, the fate of ND-loaded macrophages is still 
unknown. In addition, other in vivo studies reported that ND accumulate in the lung, liver, 
and the spleen but these studies did not investigate the long-term effect of ND in these 
organs or their ability to eliminate or degrade them (Yuan et al. 2009; Su et al. 2017). The 
size of these particles (100 nm) suggest that they may not be eliminated with urine. In 
addition, their outstanding hardness suggest that they may not be biodegradable and 
thus, they may accumulate in vital organs for a long time. Therefore, a longer-term in vivo 
study to determine the fate of ND in the body is required. Other types of nanoparticles 
(Titanium dioxide), has been shown to prime a specific activation state in macrophages 
where these cells became inflammatory and decreased the macrophage chemotactic, 
bactericidal, and phagocytic activity (Huang C et al. 2017). Although ND did not induce 
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inflammatory state in macrophages, some immune functions of macrophages are affected 
and additional studies are needed to investigate the other macrophage functions. These 
particles could be inducing a special state in macrophages where cells are not dead, but 
their responsiveness and some functions are affected by ND treatment. 
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